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ABSTRACT
FUNCTIONAL AND STRUCTU CHACTERIZATION OF AHU H4 HISTONE GENE PROMOTER
Kenneth Lynn wright
November 1990
Thesis Advisor: Janet L. Stein
Department: Cell Biology
Expression of the cell cycle dependent FOI08 human H4
histone gene is regulated at both the transcriptional and
post-transcriptional levels. We have investigated the 
promoter elements mediating the transcriptional aspects of
its regulation. A detailed in vivo and in vitro
transcriptional analysis of promoter deletion mutants from
this gene has identified three positive regulatory elements
and two potentially negative regulatory elements within the
first 1000 base pairs upstream of the transcription
initiation site. In addition, the minimal promoter located
within the first 70 base pairs is required for accurate
transcription initiation and contains one of two in vivo
identified protein-DNA interactions , site II. Binding of the
nuclear factor HiNF-D to this region was correlated with the
turn-on of histone gene transcription following stimulation
of quiescent normal diploid fibroblasts to re-enter the
proliferati phase. The most proximal positive regulatory
element contains the other in vivo identified protein-DNA
interaction, site I. Results from a series of in vitro
protein-DNA interaction studies revealed the binding of two
nuclear factors to this element. One protein, HiNF-C , is
indistinguishable from the transcription factor Sp1 while
the other , HiNF-E, is a novel, potentially histone-specific
member of the ATF transcription factor family. Binding of
HiNF-C was required to stabilize the interaction of HiNF-E
and together this region stimulated transcription 5 fold.
The near-distal transcription activator region lies
between -418 and -213 base pairs and forms a single protein-
DNA complex, H4UA-1. The interaction domain for H4UA-1
contains recognition sequences for both the thyroid hormone
receptor and the nuclear factor CTF /NF-1. The far-distal
activator region (-730 and -589 base pairs) was the
strongest positive regulatory element identified in the H4
promoter. This region increased transcription 10 fold and
contains three protein-DNA interactions. One of the factors
H4UA-2, is an ATF transcription factor closely related to
the HiNF-E interaction in the proximal positive element.
These studies have defined the functional human H4
histone promoter to be a complex, modular structure
extending at least 1000 base pairs.
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CHPTER 1
INTRODUCTION
eneral Back round
One of the requirements for cellular division is the
replication of the entire genome of the cell, thereby
producing up to two meters of new DNA which must be packaged
into the nucleus. Histones are small, highly basic proteins
principally responsible for the condensation of the DNA into
chromatin of all eukaryotes. While structurally compacting
the DNA the histones must also allow access to the genetic
information encoded therein. Thus the positioning of the
histones has the potential also to play a functional role in
gene transcription. Expression of the majority of histone
proteins is a multifaceted and tightly regulated event
coupled to DNA replication because either an excess of
unpackaged DNA or free histones is probably fatal to the
cell. Regulation of histone expression is mediated at the
transcriptional, post-transcriptional and post-translational
levels and provides an important integrated model system to
study eukaryotic gene expression. Furthermore, an
understanding of the mechanisms regulating the growth
related histone genes should provide insight into the
molecular basis of cell growth control , differentiation and
. tumorigenesis.
Histone Proteins
There are five types of histones which are divided into
the nucleosomal core histones (H2A, H2B, H3, and H4) and the
HI linker histones. The core histones are 100 to 150 amino
acids in length and have a high level of evolutionary
conservation (99). The classic example is the conservation
of the H4 histones from pea plants to calf thymus which
contain only two conservative amino acid substitutions out
of 102 (50). This level of conservation demonstrates the
critical role the histone protein structure plays in all
eukaryotic cells. The HI histones are slightly larger , about
225 amino acids and display a larger amount of diversity
both between species and within different tissues of the
same species (163).
Two copies of each of the four core histones assemble
to form an 11 nm octameric nucleosome particle (110, 135).
The DNA is then wrapped about the nucleosome nearly two full
turns to initiate the first level of chromatin formation.
Approximately 145 base pairs of DNA encircle the nucleosome
and each core particle is spaced about 60 base pairs apart.
The HI histone protein subsequently interacts with both the
linker region DNA and the nucleosome particle to organize
the nucleosomes into the basic 30 nm chromatin fiber.
Nucleosome positioning is not random in all regions of
the genome. Studies using trace amounts of DNA digestive
enzymes reveal stretches of DNA which are hyper-sensi ti ve to
the enzymes indicating that these regions are not packaged
by nucleosomes (60, 136, 210). Many of these hyper-sensitive
regions lie at the upstream side of active genes suggesting
that the presence or absence of nucleosomes in the promoter
region may play a functional role by altering the
availablity of the DNA for interaction with sequence
specific DNA binding transcription factors.
Histone Gene Or anization
Histones are encoded by a family of moderately
reiterated genes consisting of 20 to 40 copies of the
sequences coding for each of the five histone types (207).
Initial studies of histone genes in sea urchin, Drosophi7a
and other lower eukaryotes demonstrated a simple tandem
repeat organization containing one of each of the five
histone types (78, 126 211). However, the histone genes of
the higher eukaryotes including human , mouse and chicken are
organized as random clusters containing mixtures of the core
and HI histone genes (29, 61, 86, 90, 181, 184). In humans these
clusters have been localized to at least three different
chromosomes 1 , 6, and 12 ( 7 6 , 200). Interest ingly, the
clusters are interspersed with repetitive elements which may
have played a role in gene duplication leading to the
evolution of the multi-gene family (40).
Three classes of histone genes have been isolated; cell
cycle regulated genes, cell cycle independent genes, and
pseudo-genes. The cell cycle regulated genes are the most
abundant class and have a very unusual and simple structure.
These genes possess a very short 5' untranslated leader
sequence, are not interrupted by introns , and have a short
3' untranslated sequence which terminates in a unique stem-
loop structure instead of the typical polyadenylation site
(1). Each of these characteristics makes the cell cycle
regulated genes ideally suited to the large and rapid
production of histone protein required during DNA synthesis.
The cell cycle independent histone genes have a more typical
structure containing both introns and a polyadenylation site
(62, 87). These genes may be important during cellular
differentiation. Finally, pseudo-genes are non-functional
copies which have frame-shifts in the coding region or
deletions of the promoter sequences (133).
Cell C cle Re ulated Histone Gene Ex ression
The initial observations concerning the invariable 1: 1
molar ratio of histone protein to DNA combined with the
stringent requirement for histone protein to package newly
replicated DNA while unbound histones can not be stored
suggested the hypothesis of a temporal and functional
coupling between histone protein synthesis and DNA
replication (2, 161). Prescott (161) was able to demonstrate
in cell cycle synchronized cultures of 
Eup70tes eurystomus that
histone protein synthesis occurred only during the period of
DNA synthesis. Moreover, the amount of histone protein
present within a cell doubled during S phase concomitant
with the doubling of the cellular DNA content (20). These
observations were followed by a series of studies which
confirmed the temporal coupling between histone protein
synthesis and DNA replication (169, 191, 194). Subsequently,
isolation of polyribosomes from cells at different stages of
the cell cycle indicated that histone encoding polyribosomes
were selectively enriched during S phase (22).
The cloning of histone encoding cDNA and genomic DNA
fragments allowed the level of histone mRA to be monitored
throughout the cell cycle. Cell cycle regulated histone
genes were revealed to be expressed at a low, basal level
through out the cell cycle and displayed a transient
accumulation of the mRA during DNA replication which
paralleled the rate of DNA synthesis (13, 89, 160). A
functional coupling of histone expression and DNA
replication was suggested by the results of inhibiting DNA
synthesis. When hydroxyurea or cytosine arabinoside was
administered to the cells to block DNA synthesis a
concomi tant drop in the amount of histone mRA was observed
(13, 21, 24, 27). Furthermore, histone mRA levels paralleled
the changes in DNA synthesis when quiescent cells were
stimulated to proliferate (51, 75) or proliferating cells
terminally differentiated (18, 33, 193).
The pattern of expression of the cell cycle regulated
histone genes is mediated by regulation at both the
transcriptional and post-transcriptional levels.
Transcription of the histone genes was demonstrated to occur
at a low level throughout the cell cycle combined with a
transient 2 - 5 fold stimulation during the initial two
hours of S phase (14 160, 186). However, histone mRNA
accumulated 15 - 20 fold during S phase and peaked
simultaneously with DNA synthesis (13, 160). Because the
observed transcription could not completely account for this
accumulation , the result demonstrated the presence of post-
transcriptional mRNA regulation. DNA synthesis inhibitor
studies revealed that the half-life of the histone mRA was
reduced from approximately 60 minutes ' to 10 - 15 minutes
when the cells ceased DNA replication (14, 160 185). These
findings have demonstrated that it is a combination of the
burst of transcription at the onset of S phase to produce a
large amount of histone mRA combined with and followed by
an increase in the stability of the mRA which generates the
observed pattern of histone mRA expression.
RNA Pol erase II Transcri tion Initiation
The discovery of an RNA polymerizing activity in rat
liver nuclei by Weiss and Gladstone in 1950 (203) initiated
the still active research into the mechanics and regulation
of eukaryotic RNA synthesis. Three distinct RNA polymerase
activities have been defined (34, 171). RNA polymerase I
synthesizes ribosomal RNA precursors while RNA polymerase II
transcribes the protein-encoding genes and RNA polymerase
III transcribes the 5S and tRNA genes. Histone genes are
transcribed by the RNA polymerase II enzyme (53). RNA
polymerase II is a large (500 - 600 kDa), multi-subunit
complex consisting of two large subunits and 6 - 10 small
protein components (175). However, purified RNA polymerase
II lacks the ability to initiate specifically at physiologic
start sites (124). The development of in vitro transcription
systems consisting of soluble cell extracts and cloned
promoter template DNA has provided the means to dissect the
components of site specific initiation (55, 132). Five
general transcription factors required for accurate
initiation have been identified (41, 42, 59, 66, 166, 167, 172,
215). The function of only one of the factors, TFIID , has
been clearly defined. TFIID interacts directly with DNA over
the region containing the TATA box sequence (155). In higher
eukaryotes initiation always occurs 25 - 30 base pairs
downstream of the TATA box and TFIID has been suggested to
be required to align the initiation site (23). However,
heterologous reconstitution experiments reveal that
substitution of the mammalian TFIID with the yeast TFIID
still directs initiation from the mammalian start site even
though initiation in yeast occurs between 40 and 120 base
pairs downstream from the TATA box (32, 197). This indicates
TFIID is not solely responsible for alignment of the
initiation site.
Cis-actin DNA Elements and Trans-actin
Transcri tion Factors
Al though RNA polymerase II and its associated general
transcription factors are sufficient to direct site specific
initiation , most protein-encoding genes rely on auxiliary
sequence elements and their associated transcription factors
to augment and regulate transcription. The development of
DNA manipulation techniques allowed the construction of
promoter deletion mutants of cloned genes. Transcriptional
studies with deletion mutants of a sea urchin H2A histone
gene, the simian virus 40 (SV40) early promoter, the herpes
simplex virus (HSV) thymidine kinase gene and a- and 
globin genes revealed the presence of domains upstream of
the TATA box which modulated the transcription efficiency
(54, 79, 139, 141 142). These findings were refined by high
resolution point mutants and linker-scanning mutants which
defined multiple discrete DNA domains capable of regulating
transcription (140, 149, 213). Similar results have been found
within the first few hundred base pairs of many other genes
and present the picture that RNA polymerase II promoters are
modular in structure. Furthermore, cis-acting DNA elements,
referred to as enhancers , can stimulate transcription at
distances greater than 1000 base pairs from the initiation
si te and can be located both upstream and downstream from
the gene (10, 68).
The development of techniques to assay sequence
specific protein-DNA interactions directly has led to the
description of a tremendous number of transcription factors
interacting with promoters and enhancers (102, 144, 208). The
findings have clarified a few of the questions concerning
transcriptional regulation but have posed many more. Early
studies by Tj ian and co-workers led to the identification
and purification of an RNA polymerase II sequence specific
transcription factor , referred to as Sp1 (25, 58). Sp1 was
initially fractionated from HeLa cell soluble extracts based
on its ability to activate transcription from the SV40 viral
early promoter. DNase I protection studies demonstrated that
Sp1 selectively bound to the repeated GC rich boxes of the
SV40 early promoter. Similar binding sites have been
described , subsequently, in many viral and cellular
promoters positioned upstream of the TATA box motif and have
allowed the definition of a consensus recognition sequence,
5' _ G GGGCGGG G C -3 '
A A T
(107). Point mutations within this
consensus element have demonstrated that Sp1 binding
mediates the functional aspects of this DNA domain (103).
Isolation of the gene that encodes Sp1 revealed three
(cysteine)2 (histidine)2 repeated motifs that have been
suggested to interact with Zn+2 to form a "zinc finger"
structure capable of interacting with DNA (106 , 143). The
transcriptional activation by Sp1 is mediated primarily by a
glutamine rich domain distinct from the DNA binding domain
(44). The division of the DNA binding activity from the
activating domain is a common theme repeated in other
transcription factors.
In contrast to Sp1 which is a single protein
interacting with a single conserved recognition sequence,
several transcription factor families have been described
which interact with partially divergent recognition
sequences. One of the most interesting examples is the API
family of transcription factors. API was originally defined
as a sequence specific DNA binding activity that interacted
with an element in the SV40 enhancer (120) and ensuing
studies identified the recognition sequence, 5' -TGACTCA-3' ,
in many additional viral and cellular promoters and
enhancers (5 , 121). API has been the subj ect of intense
research since the classification of the proto-oncogene
fos as a member of this family (35, 164, 173). fos is an
immediate early response gene whose expression can be
triggered by a wide range of stimuli including growth
factors (39 46, 77) and thus its DNA binding activity
represents a mechanism by which cells can convert external
signals to changes in gene expression (56, 199). Multiple API
proteins including c-jun , junB , junD, fra-1 and fos have been
characterized and their shared DNA binding specificity is
reflected in a conserved region referred to as the leucine
zipper (111, 174). The leucine zipper consists of an a-helix
with 4 or more leucine residues spaced by seven amino acids
and is preceded by a highly basic region. The zipper region
is involved in dimerization and is required for DNA binding.
It has been proposed that the interaction of two leucine
zippers positions the adjacent basic regions in the proper
orientation for interaction with the DNA helix (117).
Selective and inducible dimerization between members of the
fos and jun families and of jun with other jun proteins has
been suggested as a mechanism by which API binding can
selectively regulate the many genes which contain the API
consensus recognition sequence 45). However, as yet 1 ttle
is known about the processes which promote the formation of
specific dimers.
A second transcription factor family, ATF, recognizes
DNA through a basic domain which is aligned by dimerization
through the leucine zipper motif. ATF was initially
characterized as a stimulatory activity in the adenovirus
E4a promoter and as a cyclic AMP inducible factor in the
promoter of the somatostatin gene (127 146). Purification
and cloning of the ATF factors by a number of research
groups has revealed the family to be made up of numerous
proteins with molecular masses of 39 - 120 kDa
(69 82, 130). The ATF recognition sequence,
-GTGACGT\\-3' (127), has also been defined in many
cellular and viral promoters and has been shown to be
involved in the response to E1A (119), cAMP (145) and Ca
(179). The core ATF recognition sequence is only one
nucleotide different from the API binding site and studies
have shown that each of the two factors can bind weakly to
the other site (83). Purification of ATF and API by DNA
affinity chromatography demonstrated that the major species
of both were almost identical in molecular weight (83). In
addition, the two families were shown to be immunologically
related and may belong to a super-family of leucine zipper
containing transcription factors.
A third class of DNA binding proteins is defined by the
presence of a helix-turn-helix structure required for
binding. This structure was first described for the
bacteriophage lambda proteins CRO and Cl and the CAP protein
of E. coli (3, 138, 153). Primary sequence comparison to the
highly conserved homeobox region of the Drosophi 1 
developmental regulatory genes indicated these genes also
contained a helix-turn-helix motif which directed sequence
specific DNA recognition (118, 180). Because of the high
sequence conservation of the homeobox region , homeotic genes
have now been isolated from many species (30 123, 137).
However, identification and localization of the DNA binding
sites for most of these factors are still under
investigation. One type of homeobox containing factor which
has been well defined is the octamer binding factors, OCT-1
and OCT-2 (122). These factors are distinct proteins but
interact with the same consensus DNA recognition sequence
which is found in many promoters including histone H2B and
the immunog obul in promoter and enhancer (148 , 176 , 188) .
OCT-1 is a ubiquitous factor present in most tissues, while
OCT-2 is found primarily in lymphoid tissue and is important
for the lymphoid cell-specific transcription of the
immunoglobulin genes. Interestingly, OCT-1 can not
substitute for OCT-2 in promoting immunoglobulin
transcription (170). This result raises the interesting
question of how the two factors discriminate between
recognition sequences.
In addition to the examples described above numerous
additional transcription factors and DNA binding activities
have been described during the last few years. These include
the steroid and thyroid hormone receptors and the CTF/NF-1
family. The hormone receptors utilize a zinc-finger DNA
binding motif similar to Sp1 to translate hormone induction
into the stimulation or repression of gene transcription
(15). The CTF/NF-1 family is involved in both
transcriptional activation and stimulation of DNA
replication; however , its DNA binding motif has yet to be
defined (80 105, 150, 165). Despite the volumes of information
on specific transcription factors our understanding of the
regulation of RNA polymerase II transcription is still very
limited. Many questions remain regarding 1) how a specific
binding site selects from a family of factors all with the
same consensus recognition sequence, and 2) how
transcription factors promote or repress transcription when
located near the initiation site or when located hundreds or
thousands of base pairs away. It will require an elucidation
of the interaction of the factors with each other and with
the general polymerase structure to allow an understanding
of the control of gene expression.
Histone Gene Promoters
Al though there has been much interest in the regulation
of histone gene expression, only limited promoter sequence
information is available (204). A comparison of the first
100 - 200 base pairs displays only a few obvious
similarities (92, 205). The TATA box motif is the only
component found in each of the genes. In addition, many of
the genes contain one or more sequences related to the CCAAT
box recognition sequence (73, 105). Several histone sub-type
specific elements were also suggested by the alignment
including the HI element 5 I-AACACA-3 I , the H2B element
5 I -CYTNATTTGCATAC-3 I , and the H4 element 5 I -NRTCC-3 I
To functionally address the role of promoter elements
in higher eukaryotic histone genes , several human histone
genes were examined by in vitro transcription. Sierra et al.
(182) constructed a series of promoter deletion mutants
within the initial 200 base pairs of the F0108 human H4
histone gene. This study demonstrated that sequences
extending 50 base pairs upstream of the initiation site were
sufficient to direct site specific initiation. The defined
minimal promoter contained both the TATA box and the H4
specific element. Furthermore , additional upstream sequences
appeared to augment the initiation rate. A second human H4
histone gene , Hu4a, was independently isolated and analyzed
in a similar manner by Hanly et a7. (84). The two H4 genes
while distinct have a high degree of similarity over a 30
base pair region encompassing the TATA box and the H4
specific element. It was not surprising then to find that
the minimal sequences required for in vitro transcription of
this gene corresponded to the minimal promoter defined for
the F0108 gene. In addition , sequences between -70 and -110
base pairs consisting of a G-C rich domain and a
5 I -GATTTC-3 I domain were required to achieve maximal
transcription initiation. Fine mapping of the human H2B
histone promoter by Sive et a7. (187) confirmed the
requirement of the TATA box in a minimal promoter and
defined four discrete sequence elements within the first 120
base pairs required for maximal in vitro transcription. The
H2B specific element located at -45 base pairs stimulated
transcription several fold and site specific mutations of
this region demonstrated the requirement of an octamer (OCT)
binding site consensus.
An elegant study of the F0108 human H4 gene by Pauli
et a7. (157) structurally defined regions of protein-DNA
interaction in the intact cell. Two 40 - 50 base pair
interaction domains were located in the first 200 base pairs
of the promoter. site II encompasses the TATA box and
extends approximately 25 base pairs upstream of the H4
specific element. The entire region of strong sequence
similarity between the F0108 and Hu4a H4 genes is included
within site II sugges.ting that site II may be a common
regulatory element of human H4 genes. site I is located
approximately 20 base pairs upstream of site II and contains
at the proximal side a region with striking similarity to
the Sp1 recognition sequence. with this background we
initiated a series of studies to carefully define the
specific promoter elements of the F0108 human H4 gene and to
characterize the trans-acting factors mediating the promoter
elements effect on transcription.
overview of Pro ect
Our research was divided into three sections each based
on the development of a cell free transcription system
capable of accurately and with fidelity initiating
transcription from the F0108 human H4 histone gene promoter.
The results have been schematically compiled in Appendix 
In the first section we functionally divided the in vivo
site I protein-DNA interaction into two stimulatory domains
and characterized the nuclear factors responsible for the
activation of transcription. We then extended our
examination up to 1000 base pairs from the initiation site
and defined two strong activator regions and two potential
repressor regions. Each of the activator regions was
characterized as to the protein-DNA interactions involved
and related to the factors present in site I. Finally, we
utilized the in vitro transcription system to functionally
correlate the protein-DNA interactions at site II with the
turn-on of H4 histone gene transcription during stimulation
of quiescent normal diploid fibroblasts.
. "
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CHAPTER 2
A NOVEL TRASCRIPTION FACTOR, ATF-84, AN SP1 AR INVOLVED
IN THE TRASCRIPTIONAL REGULATION OF A HUM H4 HISTONE GENE
Abstract
The promoter of the human H4 histone gene F0108
contains two regions of 
in vivo protein-DNA interaction,
site I and II. We have examined the transcriptional
contribution of site I (-124 to -90 bp) both 
in vivo and
in vitro and have identified the two trans-acting factors
mediating the transcriptional effect. Deletion mutants of
the proximal promoter were assayed in a cell free
transcription system or were fused to the chloramphenicol
acetyltransferase (CAT) reporter gene and assayed in HeLa
cells. site I increased the 
in vivo basal level of
transcription greater than 7 fold. This region was
subsequently divided into two functional domains each
contributing a 2 fold increase in cell free transcription.
Two sequence specific transcription factors, HiNF-E and
HiNF-C, have been demonstrated to interact with site I with
high affinity. The protein-DNA interactions have been
defined by combining site-directed base substitution with
the gel mobility shift assay, DNase I footprinting and DMS
interference. Binding site mutation analysis of the
proximally located HiNF-C factor demonstrates the
requirement of an intact Spl consensus recognition sequence
for HiNF-C binding and supports earlier evidence that HiNF-C
may be the transcription factor Sp1. HiNF-E interacts with
the distal half of site I and the guanine residue contact
points lie within an element with identity to the core
recognition sequence of the ATF transcription factor. site
directed mutagenesis of this element reveals it to be
required for HiNF-E binding. HiNF-E and HiNF-C have
overlapping DNase I footprints, suggesting that the two
proteins are likely to be in contact. Deletion of the HiNF-C
binding site and its protein-DNA interaction severely
reduces the binding affinity of HiNF-E as measured by
DNase I footprint protection. Additionally, HiNF-E is
detected primarily as a complex with HiNF-C in the gel
mobility shift assay. These results suggest a role for
HiNF-C in stabilizing the HiNF-E/Site I interaction. The
molecular mass of HiNF-E as determined by uv cross linking
is 84 kDa. Since HiNF-E binds to an ATF consensus sequence
we suggest that HiNF-E is a new member of the ATF
transcription factor family, termed ATF-84. These results
demonstrate that a previously undescribed ATF transcription
factor interacting with Sp1 at Site I contributes to the
regulation of this human H4 histone gene.
Introduction
Eukaryotic gene transcription is a maj or focal point
for the regulation of gene expression during normal growth
and differentiation and in the loss of growth control in
transformed and tumor cells. A clear understanding of the
transcription process and its components is a prerequisite
for understanding the broader questions of cell growth
control. Recent advances in the study of protein-DNA
interactions have revealed a complex array of trans-acting
protein factors and cis-acting DNA elements (reviewed in
(102) ). Eukaryotic gene promoters are modular in structure,
consisting of a series of regulatory sequence elements and
corresponding sequence-specific DNA binding proteins. In
addi tion the level of complexity is increased by the
presence of multiple factors with the same DNA recognition
sequence and single factors that recognize several different
DNA binding sites. Elucidating these complex pathways of
regulation supporting stringent growth control will require
detailed analysis of specific genes and promoter factors. To
this end, we have undertaken the study of the molecular
mechanisms controlling transcription of a cell cycle
regulated human H4 histone gene.
Human histone genes constitute a moderately repeated
mUlti-gene family which encode five histone sub-types
critical for the packaging of newly replicated DNA into
chromatin (31, 98, 99). The human genes are organized in
clusters of core (H2A, H2B, H3, H4) or core with HI histone
genes (29, 90, 125, 133, 181, 217) and have been identified on at
least three different chromosomes (76, 200). The majority of
histone genes are expressed in a cell cycle regulated
manner, tightly coupled both temporally and functionally to
DNA replication (178, 195). The cell cycle dependent genes
are consti tuti vely transcribed at a basal level and exhibit
a 2 - 5 fold induction of transcription during the initial
period of DNA synthesis (14 89, 160). This induction of
transcription is accompanied by a disruption of the
chromatin structure and nucleosome organization about the
promoter region (37, 147). Histone mRA accumulates rapidly
during S-phase to a level 20 - 100 fcld higher than that
detected in non S-phase cells (6, 14, 89, 160). This
demonstrates the maj or role of post-transcriptional control
in regulating the cell cycle dependent expression of histone
genes. The accumulation is mediated by an increase in
histone mRNA stability at the onset of DNA replication
followed by a selective and rapid turnover of the histone
mRA at the completion of S phase or following inhibition of
DNA synthesis (13, 185 and T. Morris, personal
communication) .
Transcription of the cell cycle regulated FOlDS human
H4 histone gene has been shown to be modulated by both
proximal and distal promoter sequence elements (74 112, 182).
We have previously shown that the proximal promoter consists
of two regions of in vivo protein-DNA interaction, site I and
II (157). site II lies between -24 and -64 base pairs
upstream from the transcription initiation site and contains
the TATA box, the histone specific element (5'-GGTCC-3 I ) and
a putative CCAAT box. Factor HiNF-D binds to the distal half
of site II (202), and occupancy of site II in vivo and
in vitro has been correlated with rendering the gene
transcribable in proliferating cells (152, 193). Furthermore
HiNF-D binding activity is stringently coupled to DNA
replication in normal diploid cells suggesting a functional
role for site II in mediating the up-regulation of histone
gene transcription during S phase (95). site I is positioned
at -90 to -124 base pairs upstream of the initiation site.
Previously we have shown that HeLa cell nuclear factor
HiNF-C binds in vitro to ,the proximal half of site I over a
consensus Sp1 recognition sequence and that factor HiNF-A is
able to interact with sequences overlapping the distal end
of site I (202). In this study we have systematically
characterized the protein-DNA interactions at site I and
have identified factors HiNF-E and HiNF-C as the functional
components of this domain. HiNF-E is proposed to be a novel
member of the ATF transcription factor family, ATF-84, with
a molecular mass of 84 kDa, while HiNF-C is shown to be
equivalent to the transcription factor Sp1. Furthermore, we
have directly determined the influence of these
transcription factors on the specificity and level of H4
histone gene transcription.
'&.
Materials and Methods
Plasmid constructions. The F0108 histone promoter is
numered from the transcription initiation site. The histone
promoter-chloramphenicol acetyltransferase 
(CAT) gene fusion
construct, F0108/CAT was derived from the previously
described construct F0002/CAT-A3 (112) by EcoRI endonuclease
digestion followed by circularization through ligation of
the proximal EcoRI site of the histone promoter 
(-213 bp) to
the EcoRI site of the vector. The construct FP201/CAT is
derived from F0108/CAT by deletion of the sequences
between -204 (SmaI) and -70 (NaeI) by restriction digestion
wi th the indicated enzymes and circularization through
blunt-end ligation of the CAT containing DNA 
fragment. The
5 I deletion mutants used for 
in vitro transcription were
prepared by BAL-31 digestion as previously reported 
(182)
and were cloned into a pUC19 vector in order to make the
vector sequences uniform. The fusion points were confirmed
by the chemical sequencing method of Maxam and Gilbert
(134).
Plasmid DNA isolation and 
urification. Plasmid DNA
was amplified in either the 
E. coli strain XL-1 Blue
(stratagene) or DH5a (Bethesda Research Laboratories) unless
otherwise indicated. Large scale preparati
(131) of
plasmid DNA was initiated by inoculating 10 ml of TYN growth
medium (1% bactotryptone, 1% yeast extract, and 0. 5% NaCl)
containing 0. 1% glucose and antibiotics (50 g/ml ampicillin
or 25 g/ml tetracycline as required by the genotype of the
plasmid or bacterium) with 40 
l of a bacterial glycerol
stock and incubated for 12 - 16 hours at 37 C. The culture
was then used to inoculate 500 ml of TYN medium and
incubated for an additional 12 - 16 hours. The bacteria were
collected by centrifugation at 4400xg for 15 minutes. The
pellet was resuspended in 10 ml of Solution 1 (25 ro
Tris-HCl (pH 8. 0), 50 ro glucose, and 10 ro EDTA
(ethylenediaminetetraaceti acid, disodium)) for 5 minutes
at 22 C followed by the addition of 20 ml of Solution 2
(1% SDS (sodium dodecyl sulfate), 0. 2 N NaOH) for 15 minutes
on ice and 15 ml of 4 C 5 M K-acetate (pH 4. 8) for an
additional 15 minutes on ice. The mixture was centrifuged at
31, 000xg for 30 minutes at 4 C and the supernatant was
collected and warmed to 22 C. The nucleic acids were
precipitated with 2/3 volume of isopropanol and pelleted at
12, 000xg for 30 minutes at 22 C. After an excess 70% ethanol
wash and resuspension of the pellet in 8 ml of TE buffer
(10 ro Tris-HCl (pH 8. 0), 1 ro EDTA), 8 grams of CsC12 and
8 ml of 10 mg/ml ethidium bromide was added. The sample
was then centrifuged for 36 hours at 180 000 x g at 22 C and
the plasmid DNA band was drained from the CsCl2 gradient.
The DNA was repeatedly extracted with I-butanol to remove
the ethidium bromide followed by extensive dialysis against
TE buffer (pH 8. 0) to remove the CSClz and the DNA was
stored at -20
single stranded M13 DNA was amplified in XLI-Blue
bacteria unless otherwise indicated by inoculating 100 ml of
TY medium (1. 6% bactotryptone, 1. 0% yeast extract, and 1.
NaCIJ with a single M13 plaque and 5 ml of an exponentially
growing culture of bacteria. The culture was incubated at
C with vigorous shaking for 6 - 18 hours. The cells were
pelleted and discarded by centrifugation at 4400xg for 30
minutes. Phage particles were precipitated from the
supernatant by the addition of 1 volume of 5xPEG/NaCl
solution (15% (wt/vol) polyethylene glycol 8000 (Kodak),
5 M NaCl J and incubation at O C for 1 - 12 hours. The
phage was collected by centrifugation at 4400xg for 15
minutes , resuspended in 5 ml TE buffer and precipitated
again with 5xPEG/NaCl. The pellet was then resuspended in
5 ml TE buffer with 1% SDS and repeatedly extracted with
phenol: CHCl : isoamyl alcohol. The single stranded DNA was
recovered by ethanol precipitation and stored in TE buffer
at 4
HeLa S3 cell culture and transfection. HeLa S3 cells
were maintained as a 37 C suspension culture at a density of
3-6 x 105 cells/ml in Joklik-modified Eagle I s minimal medium
(SMEM) supplemented with 7% calf serum (Gibco), 100U/ml
penicillin, 100 g/ml streptomycin and 1 ro glutamine. Cells
were prepared for transfection by seeding 3 x 106 cells into
100 mm culture dishes containing Eagle s-modified minimum
essential medium (EMEM) supplemented with 5% fetal calf
serum (Gibco), 5% horse serum (Gibco), 100 U/ml penicillin,
100 g/ml streptomycin and 1 ro glutamine and incubated 18 -
24 hours in a 37 C, 5% C02 incubator. Calcium phosphate
transfection of 20 - 40% confluent monolayers of HeLa cells
was essentially as described by Gorman et a7. (70). The
DNA/calcium phosphate precipitate was prepared according to
Graham and van der Eb (72). The DNA used in short term
transient expression experiments consisted of a mixture of
10 g of plasmid DNA and 10 g of carrier salmon sperm DNA
in 500 l of 250 ro CaCl2' while the DNA mixture used for
the establishment of stable cell lines consisted of 20 g of
a 20: 1 molar ratio of test plasmid to pSV2-neo plasmid
(190). The DNA mixture was added dropwise to 500 l of HEBS
buffer (50 ro Hepes (pH 7. 12IO. 05), 280 ro NaCl , 1. 5 ro
HP0 ) with constant vortexing. Four hours prior to
transfection the cells were refed with completed EMEM. The
DNA/calcium phosphate precipitate was added evenly to the
monolayer culture and incubated as above for 4 hours. The
cells were then glycerol shocked by replacing the medium
wi th 2 ml completed EMEM containing 15% glycerol for one
minute. The cells were washed with 10 ml of EMEM, refed with
20 ml completed EMEM and incubated at 37 C , 5% C02 for 24 -
48 hours. Short term transient expression was analyzed by
harvesting the cells at this point. To establish stable cell
lines, the cells were split 1: 10 and refed every 3 days with
20 ml completed EMEM Gontaining 500 g/ml Geneticin (G418,
Gibco). The Geneticin selects for cells expressing the neo
gene (an aminoglycoside phosphotransferase 3 I (II) gene) as
described by Southern and Berg (190) and resistant colonies
became visible after 9 - 10 days. Polyclonal cell lines were
developed for analysis by pooling individual colonies and
adapting the cultures into suspension cultures.
Chloramphenicol acetvltransferase (CAT) assay.
Short term transient expression was measured by CAT assays
according to Gorman et a 7. (71) and performed by Anna Ramsey-
Ewing. The transfected HeLa cells were washed 3 times with
10 ml phosphate buffered saline and scraped into 1 ml
harvesting solution (40 ro Tris-HCl (pH 7. 4), 1 ro EDTA,
150 ro NaCl) with a rubber policeman. The cells were
collected by centrifugation, resuspended in 100 l of 0. 25 M
Tris-HCl (pH 7. 8) and lysed by three freeze-thaw cycles
(-70 C to 37 C). The cellular debris was pelleted by
centrifugation in a microcentrifuge for 5 minutes at 4 C and
the freeze-thaw supernatant was decanted and saved for the
CAT assay reaction. The reactions were prepared by combining
1 of 1 M Tris-HCl (pH 7. 8), 30 l H 0, 25 l freeze-thaw
supernatant, 2. l 14c-chloramphenicol (Amersham 40 - 50
mCi/mmole), and 20 l 4 ro acetyl CoA (Pharmacia) and
incubating the mixture at 37 C for 10 - 60 minutes. The
reaction was stopped and the chloramphenicol extracted by
the addition of 1 ml ethyl acetate , vortexing, and brief
centrifugation to separate the organic and aqueous phases.
The organic phase , containing the chloramphenicol was
transferred to a new microcentrifuge tube and dried to
completion in a vacuum aspirator. The sample was resuspended
in 30 l ethyl acetate, spotted onto a silica gel thin layer
chromatography plate , and placed in an equilibrated
chloroform:methanol (95: 5 volume/volume) ascending
developing tank. The developed plate was exposed to Kodak
XA-5 film for 12 - 24 hours. Absolute values of CAT
activity obtained were subsequently normalized to the
efficiency of transfection as determined by DNA content in
the Hirt supernatant (93).
Nuclear run-on transcription. Expression of the
transfected genes in stably transformed cell lines was
analyzed by nuclear run-on transcription reactions
performed by Anna Ramsey-Ewing essentially as described by
Clayton and Darnell (38). All steps of the nuclei isolation
were carried out at 4 C. The cells were harvested by
centrifugation at 1000xg for 10 minutes and washed twice in
isotonic buffer (30 ro Tris-HCl (pH 7. 9), 125 ro KCl, 5 ro
MgClz' 10 ro p-mercaptoethanol). The cells were finally
resuspended in hypotonic buffer (30 ro Tris-HCl (pH 7. 9),
10 ro KCl 5 ro MgClz, 10 ro p-mercaptoethanol) and allowed
to swell for 15 minutes. The cells were transferred to a
Wheaton dounce homogenizer and 90% were lysed with an type
A pestle. The nuclei were collected by centrifugation at
1000xg for 10 minutes , resuspended in nuclei storage buffer
(50 ro Tris-HCl (pH 8. 3), 5 ro MgClz' 0. 1 ro EDTA, 40%
glycerol) and stored in small fractions for use in the
transcription reactions. The reactions contained 1 x 10
nuclei, 100 Ci a- P-UTP (3000 Ci/mmole, New England
Nuclear), 1 ro ATP, 0. 25 ro GTP and CTP in a final volume of
130 l and were incubated for 30 minutes at 30 C with
periodic shaking. Radiolabeled RNA transcripts were isolated
by adjusting the reaction solution to 50 ro Tris-HCl
(pH 7. 5), 600 ro NaCl , 20 ro MgClz and incubating with
100 g/ml DNase I (Boehringer Mannheim) at 20 - 22 C for 15
minutes. The solution was adjusted again to 100 ro Tris-HCl
(pH 7. 5), 150 ro NaCl, 20 ro MgClz, 12. 5 ro EDTA and
incubated with 200 g/ml Proteinase K (Boehringer Mannheim)
at 37 C for 30 - 60 minutes. Sodium acetate (pH 5. 5) was
added to 0. 2 M and the nucleic acids extracted several times
with hot phenol. The radiolabeled transcripts were
precipitated with 150 g yeast RNA by the addition of 2.
volumes 95% ethanol and incubation at -20 C for 4 - 12
hours. After centrifugation the RNA pellet was resuspended
in 10 ro Tris-HCl (pH 8. 0), 1 ro EDTA and an aliquot of each
sample was precipitated with 150 g yeast RNA and cold
10% TCA (trichloro-acetic acid). TCA-precipitable counts
were determined by liquid scintillation spectrometry.
Nitrocellulose southern blots (189) were prepared containing
restriction endonuclease digested DNA fragments
complementary to the RNA transcripts of interest and various
control DNA fragments. The blots were pre-hybridized in
20 ro Tris-HCl (pH 7. 4), 1 M NaCl, 2 ro EDTA , 0. 1% SDS
(sodium dodecyl sulfate), 5x Denhardt' s (100x Denhardt'
2% (w/v) ficoll 400 , 2% (w/v) polyvinylpyrrolidone),
250 g/ml E. coli DNA and 12. 5 ro sodium pyrophosphate at
C for 6 hours. Hybridization was with 5 x 105 - 1 X 10
TCA-precipi table counts of radiolabeled RNA per ml of
hybridization solution (20 ro Tris-HCl (pH 7. 4), 1 M NaCl,
2 ro EDTA , 0. 1% SDS, 2. 5x Denhardt' , 250 g/ml E. coli DNA)
at 65 C for 72 hours. The blots were washed at 65 C for 15
minutes in fresh pre-hybridization solution, 1 hour in
2x SSC/O. 1% SDS (20x SSC: 3 M NaCl, 0. 3 M sodium citrate
pH 7. 0), overnight in 2x SSC/O. 1% SDS, and 1 hour in
- - - -
2x SSC/O . 1% SDS. The washed blots were air dried and
exposed to Kodak XA-5 film.
Pre aration of nQclear extracts. Nuclear extracts were
prepared from 1x109 exponentially growing HeLa S3 cells
essentially as described by Dignam et a 1. (55), except 2 ml
of 600 ro KCl was used to extract the nuclei. All steps were
done at 4 C and all buffers except the phosphate buffered
saline contained fresh 0. 5 mM phenylmethylsulfonyl fluoride
(PMSF), 0. 5 ro dithiothreitol (DTT) , and 5 g/ml each of
pepstatin A, antipain, leupeptin, and chymostatin (Sigma).
The cells were harvested by centrifugation at 1000xg for 10
minutes, washed in 20 ml of phosphate buffered saline
(137 ro NaCl, 2. 7 ro KCl, 8. 1 ro Na HP04' 1. 5 ro KH
(pH 7. 0)) and collected by centrifugation as before. The
cells were resuspended in 20 ml Buffer A (10 ro Hepes (N-2-
hydroxyethylpiperazine-N' -2-ethane sulfonic acid) (pH 7. 9
with KOH), 1. 5 ro MgClz, 10. 0 ro KCl), allowed to stand for
10 minutes to swell, centrifuged as before, and resuspended
in 8 ml of Buffer A. The cells were lysed in a 15 ml Wheaton
dounce homogenizer with a type A pestle. Cell disruption was
monitored by examination of aliquots under the microscope
until less than 10% of the cells remained intact. The nuclei
were collected by centrifugation as before , washed in 8 ml
of Buffer A and re-collected by centrifugation at 25, OOOxg
for 20 minutes. The packed nuclear pellet was resuspended in
2 ml of Buffer C (20 ro Hepes (pH 7. 9), 20% glycerol, 600 ro
KCl, 1. 5 ro MgClz, 0. 2 ro EDTA) by two gentle strokes of a B
pestle in a 7 ml Wheaton dounce homogenizer. Extraction was
for 30 minutes with constant stirring. The extracted nuclei
were pelleted by centrifugation at 25, 000xg for 30 minutes
and the clear supernatant was dialyzed in a 2000 molecular
weight cut-off dialysis bag (Spectra/Por, Spectrum Medical
Industries , Inc. ) against 2 changes of 500 ml Buffer D
(20 ro Hepes (pH 7. 9), 20% glycerol, 100 ro KCl, 0. 2 ro
EDTA). After dialysis the sample was cleared by
centrifugation at 25, OOOxg for 20 minutes and 25 l aliquots
of the supernatant were quick frozen in liquid nitrogen and
stored at -70
In vitro transcri tion. Transcription from linearized
template DNA was essentially as described by Dignam et a7.
(55). The histone templates were linearized at the unique
NcoI restriction site to produce a run-off transcript of 279
nucleotides. Transcription from covalently closed circular
template DNA was performed by pre-incubating the DNA and
50 - 100 g of crude nuclear extract in 21 l at 4 C for 15
minutes in a buffer containing 12 ro Hepes (pH 7. 9 with
KOH), 12% glycerol , 60 ro KCl, 8 ro MgClz, 0. 3 ro DTT,
12 ro EDTA. Transcription was initiated by the addition of
280 M of ATP, CTP, GTP, and UTP (Sigma) to bring the final
volume to 25 l and the reactions were placed at 30 C for 30
minutes. The reactions were stopped by making the sample
50 ro Na-acetate, 0. 5% SDS, 0. 5 mg/ml yeast t-RNA in a total
volume of 100 l. The nucleic acids were isolated by
phenol: CHCl : isoamyl alcohol extraction, precipitated and
resuspended in 49 l of DNase I digestion buffer (40 ro
Tris-HCl (pH 7. 9), 10 ro NaCl, 6 ro MgC1 J. After digestion
with 1 unit of RQ1 RNase free DNase I (promega) for 15
minutes at 37 C the RNA transcripts were isolated by
extraction as before and directly used for nuclease Sl
protection analysis.
Sl nuclease rotection. The Sl nuclease protection
analysis was performed using a modification of the method of
Berk and Sharp (17, 125). The probe used was a single end-
labeled DNA fragment overlapping the transcription
initiation site (-418 - +279 base pairs), which yields a 279
nucleotide protected fragment corresponding to the
accurately initiated F0108 H4 histone mRA. The probe was
labeled and isolated as described for the gel mobility shift
assay. The RNA was precipitated with 10 ng of probe and
20 g of glycogen by the addition of NaCl to 0. 25 M and
3 volumes of ethanol. The pelleted nucleic acids were
resuspended in 2. l of 5x hybridization buffer (2 M NaCl,
2 M Pipes (pH 6. 4), and 5 ro EDTAJ and 10 l of
. . 
recrystallized formamide, denatured by incubation at 100
for 10 minutes and transferred directly to 5S C for 3 - 12
hours. The reactions were then placed on ice and digestion
was initiated by the addition of 100 l of Sl buffer (0. 25 M
NaCl, 0. 03 M Na-acetate (pH 4. 6), and 4 ro ZnS0 )' 10 
salmon sperm DNA, and 440 units of Sl nuclease (Boehringer
Mannheim). The digestion reactions were for 1 hour at 22
followed by 15 minutes on ice and were stopped by the
addition of 10 l 10% SDS and 4 l 0. 5 M EDTA. The protected
nucleic acids were recovered by phenol: CHCl : isoamyl alcohol
extraction followed by ethanol precipitation with 2 g of
glycogen and 2. 5 volumes of 95% ethanol at -20 C overnight.
The protected probe was recovered by centrifugation
resuspended in 5 L of loading dye (99. 8% formamide , 0.
bromophenol blue , 0. 1% xylene cyanol), heated to 100 C for 3
minutes and resolved on a 6% polyacrylamide denaturing gel
(0. 3% N, N'- methylene-bisacrylamide , 7. 75 M urea , 1xTBE
(20XTBE: 89 ro Tris-HCl (pH 8. 3), 89 ro boric acid , and
20 ro EDTA)) followed by autoradiography.
Gel mobilit shift anal sis. The gel mobility shift
analysis (67) was performed essentially as described by
staudt et a 7. (192). DNA probes were prepared by digestion
of the pD3 plasmid (contains only site I (-204 to -72 bp)
cloned into the SmaI-PstI sites of a pUC19 vector) with
HinDIII under the conditions recommended by the supplier
followed by 5' end labeling 5 g with 32p in a 25 
reaction mixture containing 100 Ci 1_ p-ATP (3000
Ci/mmole, New England Nuclear), and 2. 5 l of lOx kinase
buffer (0. 5 M Tris-HCl (pH 7. 6), 0. 1 M MgC12' 50 ro DTT,
1 ro spermidine, and 1 ro EDTAJ and 15-30 units of T4
polynucleotide kinase (cloned, u. s. Biochemical). The
reaction was allowed to proceed for 30 minutes at 37 C then
stopped by the addition of 2 l of o. 5 M EDTA. The DNA was
recovered by phenol: CHC1 : isoamyl alcohol extraction and
subjected to digestion with DdeI to generate the 99 base
pair site I probe. The probe was isolated by electrophoresis
on a 4% native polyacrylamide gel (0. 2% N, N'- methylene-
bisacrylamide, 1xTBE), localized by autoradiography and
electroeluted from the gel with the Elu-trap system
(Schleicher & Schuell). Protein-DNA binding reactions were
allowed to occur between 2 - 4 ng of 32P-radiolabeled site I
DNA probe (-158 to -71 bp) and 1 - 10 g of crude HeLa
nuclear extract in a final volume of 20 l containing 4 
of poly (dI-dC)' (dI-dC), 12 ro Hepes (pH 7. 9), 12% glycerol,
60 ro KCl , and 0. 37 ro DTT. Binding occurred during a 30
minute incubation at 22 C and samples were immediately
loaded onto a high ionic strength 4% native polyacrylamide
gel (0. 1% N , N' methylene-bisacrylamide , 50 ro Tris-HCl
- - -,--
380 ro glycine, 2 ro EDTA, pH 8. 5). Electrophoresis was at
200 V constant and the gels were maintained at 
throughout the run. The electrophoresis was stopped when the
marker bromophenol blue dye reach the bottom, the gels were
vacuum dried onto Whatman 3MM paper and exposed to Kodak 
film at room temperature for 12 to 16 hours. The specific
oligonucleotide competitor for distal site I is:
5' -GATCCGGAAGAATGACGAATGTCGAGA-3 '
3 ' -GCCTTTTCTTTACTGCTTTACAGCTCTCTAG-5 '
The ATF oligonucleotides were the generous gift of Dr.
Michael Green (81, 82) and the consensus Sp1 oligonucleotide
has been described (206). The H3 histone distal site II
01 igonucleotide is:
5' -GATCTGCACAGAGATGGACCAATCCAAGAAGGG-3 '
3' -ACGTGTCTCTACCTGGTTAGGTTCTTCCCCTAG-5 '
Gel mObility shift analysis of the purified protein
preparations was the same except the poly(dI-dC). (dI-dC) was
omitted and gels were exposed for 16 - 24 hours at -70
site-directed muta enesis. Selected base substitutions
were introduced into the promoter of the H4 histone gene by
oligonucleotide directed mutagenesis without phenotypic
selection , essentially as described by Kunkel (113). Uracil
containing single strand M13 DNA carrying the 1. 85 kB
EcoRI/HinDIII fragment of F0108 , was prepared by
amplification in the E. coli strain CJ236 (dut - ung ) (a
gift of Dr. Barbara Bachmann, E. co 7 Genetic stock Center
Yale Uni versi ty) in normal growth medium supplemented with
o. 25 g/ml uridine (Boehringer Mannheim). Mutations were
introduced in complementary synthetic oligonucleotides
containing the base substitutions in either distal site 
5' -GAGGAACAGAAGAcATcACtAATGTCGAG-3 " or proximal
si te I, 5' -CGAGAGttCGGGGAC-3 ' . A 4 - 8 fold molar excess of
oligonucleotide was 5' phosphorylated with 2 units of cloned
T4 polynucleotide kinase (US Biochemical) in a 2 
reaction mixture containing 2 l of lOx kinase buffer
(500 ro Tris-HCl (pH 7. 5), 100 ro MgC12' and 50 ro DTT) and
25 ro ATP for 60 minutes at 37 C. The reaction was stopped
by the addition of 3 l of 100 ro EDTA and heating to 70
for 10 minutes. The single strand DNA template (1 g) was
added to the oligonucleotide, the buffer was adjusted to
1xSSC (20x SSC: 3 M NaCl, 0. 3 M sodium citrate , pH 7. 0), and
the mixture was heated to 80 C and allowed to cool slowly
over several hours. synthesis and ligation of the second
strand was initiated by the addition of 20 l of
5x polymerase mix (100 ro Tris-HCl (pH 8. 8), 10 ro DTT,
50 ro MgC12' 2. 5 ro dATP , dCTP, dGTP, dTTP, and 5 ro ATP),
5 units T4 DNA polymerase (Boehringer Mannheim), 2. 0 units
T4 DNA ligase (Boehringer Mannheim) in a final volume of
100 l. The reactions were incubated for 5 minutes at room
temperature, then 2 hours at 37 C and were stopped by the
addition of 3 l of 0. 5 M EDTA. The mutations were recovered
by transfection of half of the final reaction volume into
wild type E. coli strain XLI-Blue (stratagene) which degrades
the uracil containing parental strand and amplifies the
mutagenized strand. Mutations were confirmed by enzymatic
sequencing (sequenase , US Biochemical) and the 1. 85 kB
EcoRI/HiNDIII histone gene containing fragment was cloned
back into pUC19.
DNase I rotection. DNase I footprinting was performed
as described by Augereau and Chambon (9) and used the same
probe as in the gel mobility shift assay. Binding reactions
in a final volume of 10 l consisted of 1 g poly(dI-dC)'
(dI-dC), 0. 3 ro DTT, and the remaining 6 l was made up of
the indicated amount of nuclear extract plus nuclear extract
storage buffer (Buffer D). The reaction mixture was pre-
incubated for 15 minutes on ice then 5 fmole of the single
end radiolabeled DNA probe was added and the reaction was
shifted to 20 C for an additional 15 minutes. A 1 minute
digestion was initiated by the addition of O. 5 l MgClz and
l of a 62. l stock of DNase I (Boehringer
Mannheim). The digestion was stopped by the addition of
50 l of stop Buffer (0. 65% SDS, 20 ro EDTA) then the
samples were extracted with phenol: CHC1 : isoamyl alcohol and
ethanol precipitated. Resolution of the DNase I pattern was
by electrophoresis on a 6% or 8% denaturing polyacrylamide
gel with 7. 75 M urea as described for Sl nuclease
protection. Control lanes contained 3 - 20 g of bovine
serum albumin (BSA) and were treated the same except the
amount of DNase I used was 5 fold less. The relative
affinities of the factors for the binding sites were
assessed by determining the degree of change in the
intensity of the footprint protection as measured by
densitometry.
UV cross-linkin of nuclear roteins. Molecular mass
determination by UV cross-linking was performed as described
by Chodosh et a7. (36). Uniformly labeled DNA probes were
synthesized from a single stranded M13 template containing
the site I binding domain. Template DNA (10 g) and an
equimolar amount of the M13 17 base pair universal primer
were annealed by heating to 100 C followed by slow cooling
over several hours in a 100 l reaction mixture containing
10 ro Tris-HCl (pH 7. 5), 10 ro MgC12' 50 ro NaCl, 1 ro DTT,
and 100 g/ml BSA. Synthesis of the second strand was
initiated by the addition of 500 Ci a- P-dCTP (New England
Nuclear, 3000 Cijmmole), 50 M dATP , 50 M dGTP , 5 M dCTP,
50 M 5-bromo-2' -deoxyuridine 5' -triphosphate (Pharmacia) in
the same buffer as before and adding 24 units of the Klenow
fragment of E. coli DNA polymerase I (Bethesda Research
Laboratories). The reaction was allowed to proceed for 90
minutes at 16 C and was stopped by heating to 68 C for 10
minutes. The buffer was adjusted to the recommended
concentrations for digestion with DdeI and HinDIII and
digestion proceeded for 3 hours. The digested DNA was
precipitated by the addition of 0. 3 M ammonium acetate and
2 volumes of ethanol followed py centrifugation at room
temperature. The uniformly labeled site I probe was isolated
on a 4% polyacrylamide gel as described above. Protein-DNA
interactions were formed exactly as described for the gel
mobility shift assay except the probe was approximately
250, 000 cpm. The binding reactions were then subjected to UV
light (302 nm, 7000 w/cm ) at a distance of 5 cm for 5 to
60 minutes. After cross-linking the excess DNA was digested
by the addition of 1 l of 200 ro CaC12' 4 units DNase I
(Worthington) and 1 unit micrococcal nuclease (Boehringer
Mannheim) for 30 minutes at 37 C. The cross-linked proteins
were analyzed by discontinuous (SDS) polyacrylamide gel
electrophoresis as described below and autoradiographed.
DNA affinit chromato site I DNA probes were
prepared with biotin and 32p using a T4 DNA polymerase
replacement synthesis method essentially as described by
Kasher et al. (108) and performed with the assistance of
Dr. Neil Aronin. Plasmid DNA (pD3, 50 g) containing the
site I region was linearized at the HinDIII restriction site
31 base pairs 3' to the site I footprint and incubated for
60 seconds at 37 C in a final volume of 100 l containing
33 ro Tris-acetate (pH 7. 9), 66 ro potassium acetate , 10 ro
magnesium acetate , 100 g/ml bovine serum albumin, 0. 5 ro
DTT and 10 units of T4 DNA polymerase (Boehringer Mannheim)
to excise 10 - 20 nucleotides from the 3' -hydroxyl termini.
Termination of the exonuclease reaction and initiation of
the re-synthesis reaction was by the addition of 200 M dATP
and dGTP, 40 M dCTP, 20 M biotin-16-dUTP (Boehringer
Mannheim), and 100 Ci a- P-dCTP (New England Nuclear,
3000 Ci/mmole) and continued incubation at 37 C for 45
minutes. The extension was chased to completion for 20
minutes at 37 C by the addition of an additional 20 M dCTP
and 20 M dUTP and the reaction was stopped by heating the
mixture to 75 C for 15 minutes. The reaction mixture was
adj usted to the buffer conditions recommended for digestion
with DdeI and digestion was carried out for 2 hours followed
by isolation of the probe as described previously. The
binding of the crude nuclear extract to the probe was
exactly as described in the gel mobility shift protocol
except all components and the final volume were scaled up
50 fold. The protein-DNA complexes were recovered by
addition of a 5 fold molar excess of streptavidin (1. l of
1 mg/ml stock; Boehringer Mannheim) and incubation for 5
minutes at 22 C followed by a 30 minute incubation at 4 C on
a slowly rotating wheel with 9 
l of biotin-cellulose
(pierce, pre-treated with 500 
g/ml insulin and 200 
poly (dI-dC) . (dI-dC)). The protein-DNA-streptavidin-biotin-
cellulose complex was then pelleted by a brief
centrifugation at 4 C and the pellet was resuspended in
500 l of gel mobility shift binding buffer and transferred
to a new tube. The mixture was gently mixed for 2 minutes
and pelleted as before. The proteins were eluted from the
DNA by resuspension of the pellet in 20 
l of elution buffer
(20 ro Hepes (pH 7. 9), 1 M KCl, 12% glycerol, 5 ro MgCl
1 ro EDTA, 1 ro DTT, and 200 g/ml insulin) and incubation
for 20 minutes at 4 C with gentle rocking followed by
pelleting of the biotin-cellulose complex. The supernatant
containing the proteins was recovered and half was
immediately frozen at -70 C while the other half was diluted
10 fold with KCl-free elution buffer and stored at -70
C in
aliquots for DNA binding studies.
Silver stain and western blot anal sis. purified
proteins were resolved by 10% denaturing (SDS) discontinuous
gel electrophoresis as described by Laemmli (116) and
performed with assistance of Dr. Neil Aronin. The protein
fraction was mixed at a 1: 1 ratio with 2xSDS sample buffer
(126 ro Tris-HCl (pH 6. 8), 20% glycerol, 2% SDS, 300 ro
p-mercaptoethanol, and bromophenol blue), heated to 90 C for
3 minutes and loaded onto a 4% polyacrylamide-SDS stacking
gel (375 ro Tris-HCl (pH 6. 8), 4% polyacrylamide, 0. 1% N'-
methylene-bisacrylamide, 0. 1% SDS) and electrophoresed into
a 10% polyacrylamide-SDS resolving gel (same buffer as
stacking gel except pH = 8. 8). The gel was electrophoresed
at 7 - 15 mA until the dye front was within 2 cm of the
bottom. The silver staining (209) was accomplished by
soaking the gel for 30 minutes in 100 ml of staining
solution prepared by adding 4 ml of a 1. 18 M AgN03 solution
drop-wise to a mixture of 21 ml 0. 36% NaOH and 1. 4 ml NH
and subsequently increasing the volume to 100 ml with H
The gel was washed 3 times with H 0 for 5 minutes each and
developed in 250 ml of a solution of 0. 26 ro citric acid and
019% formaldehyde until the bands were clearly visible.
The reaction was stopped by several quick rinses in water
and soaking the gel for 1 hour in 50% methanol-10% acetic
acid. Electrophoresis of the purified protein for western
blot analysis was described as above except instead of
staining the gel it was electrophoretically transferred to
Immobilon-P membrane (Millipore) at 100 ID for 12 hours in a
transfer buffer of 20 ro Tris-HCl (pH 8), 150 ro glycine,
and 20% methanol. The blot was serially treated for 1 hour
with 2% BSA, for 2 hours with anti-APl rabbit anti-serum
(diluted 1:1000, a gift of Dr. M. Green) and for 1. 5 hours
with alkaline phosphatase conjugated anti-rabbit anti-serum
(diluted 1: 3000). All dilutions and washes between anti-
seru applications were with a buffer of 10 ro Tris-HCl
(pH 7. 6) and 150 ro NaCl. The alkaline phosphatase labeled
bands were then visualized by treatment of the blot with
commercially available Nitro-blue tetrazolium chloride (NBT)
and 5-bromo-4-chloro-3-indolyl-phosphate p-toluidine salt
(BCIP) .
Resul ts
The F0108 human H4 histone gene proximal promoter
consists of two regions of protein-DNA interaction 
in vivo,
site I and II. We have determined the contribution of site I
in modulating the extent of H4 histone gene transcription by
the construction and analysis, both 
in vivo and in vitro, of a
series of 5' and internal deletion mutants. Furthermore, to
understand the molecular mechanisms by which site I
influences the initiation rate, we have characterized the
proteins interacting at this region.
Transcri tional contribution of site I in vivo. The
initial approach to understanding the role of site I in
transcription was to examine the effect of an internal
deletion of site I in a short-term transient expression
system. Histone promoter deletions, spanning from -213 bp to
-70 bp, were fused to the CAT structural gene 10 base pairs
upstream of the histone transcription initiation site
(Figure 2-1C). The constructs were transfected into HeLa S3
cells and 48 hours later whole cell freeze-thaw supernatants
containing the expressed CAT protein (71) and Hirt
supernatants of the transfected plasmid DNA (93) were
prepared. The levels of CAT activity in the whole cell
lysates were assayed by thin layer chromatography and
Figure 2-1. In vivo anal sis of Site I deletion mutants.
A) CAT assay of HeLa cells transfected with the indicated
histone promoter-CAT fusion constructs. The un-acetylatedand two acetylated forms of chloramphenicol are designated
A, B and C respectively. Lanes: CM, control with no CAT
enzyme; CAT, control with 0. 9 units of purified CAT enzyme;
108CAT and 201CAT , extracts from cells transfected with the
indicated construct. B) Nuclear-run transcription analysis
of stable cell lines containing the indicated constructs.Radiolabeled RNA transcripts were hybridized to Southern
blots containing immobilized plasmid DNA of H4 human histone
gene (F0108), human H2B histone gene
, CAT coding sequence
and 18S ribosomal gene. C) S hematic showing deletion
constructs and quantitation of the CAT activity and nuclearrun-on transcription. CAT activity was normalized to the
transfection efficiency as determined from the Hirt
supernatant (93) and nuclear run-on transcription was
normalized to the endogenous 18S ribosomal transcript.
H2B
CAT
185
..-
...
, i
normalized for transfection efficiency by quantification of
the plasmid DNA content in Hirt supernatants. The results
(Figure 2-1A) indicat€that deletion of the site I protein-
DNA interaction domain severely reduced the CAT acti vi ty
(construct F0108/CAT vs FP201/CAT). After normalization with
respect to the transfection efficiency, site I was measured
to increase CAT activity 7 fold over a minimal histone
promoter. Further deletion of the promoter, which disrupts
the site II protein-DNA interaction domain, abolished all
specific initiation (112) and reduced CAT activity to
background levels (data not shown).
In order to demonstrate directly a role for site I in
modulating transcription and to address the effect of
integration into a chromosomal structure , we established
stable transformed cell lines containing each of the
deletion constructs. The expression of each construct was
assayed by nuclear run-on transcription and normalized to
the level of 18S ribosomal gene expression as an internal
control (Figure 2-1B). The findings were consistent with the
transient expression results and demonstrate that site I is
responsible for a 7. 0 to 7. 5 fold increase in transcription
from this histone promoter in vivo. The effect of site I on
transcription was independent of integration into a
chromosomal structure , as the relative contribution of
site I to transcription was approximately the same in both
the transient transfection and stable cell line expression
systems.
site I contributes to the level of cell free
transcri tion. To directly address the molecular mechanisms
operative wi thin the proximal promoter, we developed an 
vitro transcription system capable of faithfully initiating
transcription of the human H4 histone gene. Five 5' deletion
mutants created by Bal 31 digestion (182) were cloned into a
pUC19 vector and used to assess the contribution of the
proximal promoter in vitro. 
Initially, linearized templates
of the deletion mutants were employed in a standard run-off
transcription assay (132). This system failed to detect any
cis-acting elements upstream of the TATA box motif 
(data not
shown). Because this result was in direct contrast to the 
vivo transcription results, we examined the possibility that
closed supercoiled templates were required to observe an
effect by the cis-acting DNA elements. The transcription
initiation complex was allowed to form by pre- incubating
high salt extracted nuclear proteins with supercoiled DNA of
the deletion mutants linked to the normal histone structural
gene. Transcription was initiated by the addition of
ribonucleoside triphosphates and the resulting mRA was
quantified by densitometry of autoradiograms from Sl
nuclease protection assays. The template DNA was relaxed
during the initial pre-incubation period into a mixture of
approximately 80% relaxed covalently closed circles and 20%
with up to 8 supercoils (Figure 2-2). This mixture was
maintained for up to 4 hours which is in great excess of the
time required for the transcription reaction.
The results shown in Figure 2-3A and 2-3B indicate that
the supercoiled cell free transcription system accurately
reflects the in vivo transcription results. A comparison of
the 5' deletion mutants JUC56 (-73 bp) and KUC8 (-155 bp)
revealed that the addition of site I sequences stimulated
transcription greater than 5 fold. Further subdivision of
this element at -99 bp (JUC50) demonstrated that site I
contains at least two distinct functional domains. Both
halves contribute approximately equally to the activity of
site I. Additional sequences up to -185 bp (LUC14) and the
distal half of site II do not contribute significantly to
the level of transcription. It is interesting to note,
however, that site II has been implicated as being required
for correct initiation during transient transfection
experiments (112) and unpublished results). These results
establish that site I is a functional cis-acting element
capable of stimulating transcription of the human H4 histone
Figure 2-2. structure of lasmid DNA after incubation with
nuclear extracts. Maximally supercoiled plasmid DNA was
incubated with HeLa nuclear extracts under the same
condi tions of the cell free transcription reactions except
the nucleotides were omitted. Reactions were stopped by
addition of 0. 5% SDS and assayed on a 0. 8% agarose gel.
Lanes 1 - 8, increasing duration of incubation from 10
seconds to 30 minutes.
relaxed ..
maximally
supercoi led..
Figure 2-3. Cell free transcri tion anal sis of H4 histone
romoter deletions. Supercoiled plasmid containing a series
of promoter deletion mutants were transcribed in a nuclear
extract system and transcripts were assayed by Sl nucleaseprotection. A) Autoradiograph of Sl analysis. lane 1 -
LUC14, lane 2 - KUCS, lane 3 - JUC 50, lane 4 - JUC56 , lane
5 - JUC67. Arrow indicates accurately initiated transcripts.
B) Schematic of the promoter deletion constructs and
quantitation of the average of at least five independenttranscription experi.ments.
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gene. In addition, the effectiveness of this element 
in vitro
indicates that the necessary protein factors involved are
contained in the high salt nuclear extract.
HiNF-E and HiNF-C are distinct bindinq events at
site I. The protein factors interacting at site I were
investigated to reveal the mechanisms by which site I
influences transcription. The initial approach was to employ
the gel mobility shift assay to address the number and types
of interactions occurring. A radioactive DNA probe spanning
only site I (-156 to -72 bp) was incubated with the high
salt extracted nuclear proteins from HeLa cells. site I
sequences formed protein-DNA complexes resulting in two
prominent shifted bands and several light bands (Figure
2-4). The specific interactions in each complex were defined
by DNA binding site competition with synthetic
oligonucleotides. An oligonucleotide representing the distal
half of site I (-125 to -101 bp) competed one of the lower
complexes designated HiNF-E and partially competed the upper
prominent complex, HiNF-C+E (Figure 2-5). Because site I has
a region of sequence similarity to the ATF transcription
factor consensus site , we examined whether either a
consensus ATF recognition sequence or an ATF binding site
from the adenovirus E4a promoter would compete with the
Figure 2-4. Gel mobilit shift anal sis of the site I
rotein-DNA interactions. A radiolabeled Site I probe (-158
to -71 bp) was incubated with increasing concentrations (0.
to 8 g) of HeLa nuclear extract and resolved on a
polyacrylamide gel as described in (192).
-i.
:2: - I
.. HiNF-C+E
.. HiNF-C
(:;C
. . .\ .
.. HiNF-E
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ncreaslng protein
Figure 2-5. Com etition of the site I rotein-DNA com lexes
wi th consensus ATF and S 1 oli onucleotides. Gel mobility
shift analysis of the site I probe incubated with 4 g of
HeLa nuclear extract and 500 fold molar excess of specific
oligonucleotides. Lanes: 1, no competitor; 2, distal Site I
(DS-1); 3, consensus ATF (CATX3 , 82); 4, ATF site from the
E4 promoter (pE427X1 , 81); 5, non-specific oligonucleotide
from the histone H3 promoter (H3-SII); 6 , Sp1 consensusdimer.
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site I interactions. Both ATF recognition sites competed
HiNF-E and HiNF-C+E binding, though not as effectively as
the distal site I competitor 
Figure 2-5). A third band that
migrated more rapidly than HiNF-E was also competed by the
DNA fragments containing the ATF binding sites but is
apparentlY unrelated- to the ATF site in site 
I, as mutations
of the ATF recognition sequence 
(see below) did not disturb
this interaction.
Because the proximal half of site I contains a sequence
with strong similarity to the Sp1 consensus binding 
site, we
used a dimer of the Sp1 consensus as an oligonucleotide
competitor. This 01 igonucleotide effectively competed both
of the prominent shifted complexes, HiNF-C and HiNF-C+E
(Figure 2-5). An unrelated oligonucleotide was unable to
compete specifically for any of the 
bands. The results
suggest that HiNF-C is related to Sp1 binding to the
proximal half of site I while HiNF-E is an interaction in
the distal half related to an ATF consensus 
sequence. The
ability of both specific oligonucleotides to compete for the
upper prominent band indicates this band is related to
binding of both HiNF-E and HiNF-C, and suggests that site I
is a bipartite structure with at least two distinct
protein-DNA binding events.
HiNF-E re ires an ATF consensus site for bindin
HiNF-C re ires an intact S 1 consensus site.
site-directed
base substitution is a highly specific method to define the
binding site requirements of protein-DNA interactions. We
created two independent mutations of site I to resolve the
binding sites of HiNF-E ahd HiNF-C. 
Previously, we have
identified by 
in vivo genomic sequencing (157) and in vitro
DMS fingerprinting (202), a series of highly specific
protein/guani residue contact points at site I. These
contacts are arranged into two groups, one in the proximal
half over the region of similarity to the Sp1 consensus
recognition site and the other group in the distal half
about a potential ATF recognition sequence. The contact
points were used as a guide for the construction of the
site-directed mutations. Mutation 1 alters the two guanine
contacts in the distal half of site I as well as one
adjacent nucleotide (Figure 2-6) and disrupts the ATF
binding site consensus core, 5' -TGACG-3'
. Examination of the
protein-DNA interactions reveals that both the HiNF-E and
HiNF-C+E complexes were abolished by the mutation 
(Figure
2-7). The gel mobility shift pattern is analogous to the
wild type pattern after competition with the distal site I
or ATF consensus oligonucleotide and implies that all of the
Figure 2-6. Schematic of the site I domain. Dark lines
indicate the extent of the in vivo DNase I footprint and
filled circles denote the methylation protected guanine
residues (157). Brackets define the in vitro Dnase I
footprints of HiNF-E and HiNF-C determined in the absence of
binding by the other factor. Filled boxes designate the ATF
and Sp1 consensus recognition sequences. The base
substitutions in Mutation 1 and Mutation 2 are indicated
below.
Site I
...
124 AAAGAAATGACGAATGTCGAG CAATTG -
TTTTCTTT TTACAGCTC GTTAAC
HiNF-E HINF-
Mut.1 -
-- - -
C--
- - - - - - - - - - - - - - --
Mut.2 --
-
TT -------
Figure 2-7. Effect of s ecific base substitutions on the
site I rotein-DNA interactions defines two bindin events.
Gel mobility shift analysis of site I probes containing
either the wild type sequence (wt) or mutation 1 (mut. 1) or
mutation 2 (mut. 2) as detailed in Figure 2-6. Each probe was
incubated with three concentrations of HeLa nuclear extract( 4, 6 , 8 J.g).
mut. muLl!
...
HiNF-C ..
0,"
";;'
II .,HiNF-C+E'"
.., -- 
H iNF- E'"
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interactions in the distal half are due to binding at the
ATF consensus site.
Mutation 2 substitutes two adjacent guanine nucleotides
of the Spl consensus with thymine residues (Figure 2-6).
This mutation abolishes purified Sp1 binding activity in
other genes (103). The effect on the site I gel mobility
shift pattern (Figure 2-7) was to abolish both prominent
bands while increasing the intensity of the HiNF-E band.
This result mimics consensus Sp1 oligonucleotide competition
of the wild type pattern and further confirms the presence
of an Sp1/Site I interaction.
The upper prominent shifted band is detected only at
high concentrations of protein extract, subsequent to the
appearance of HiNF-E and HiNF-C and is eliminated by
mutations to or competition with either the ATF consensus
binding site or the Sp1 binding site. These results can be
most directly interpreted to signify that this upper
prominent band is a complex of both the Sp1 interaction,
HiNF-C, along with the ATF interaction, HiNF-E.
HiNF-E Site I interaction is stabilized b HiNF-C
bindin Gel mobility shift analysis has demonstrated that
HiNF-E and HiNF-C are capable of binding independently and
simultaneously to site I. To better understand this
relationship, we examined , the position and relative
affinities of the interactions by DNase I footprint
analysis. Crude nuclear extract incubated with the wild type
site I probe protected a region of 36 base pairs (-122 to
-87 bp) that spans the Sp1 and ATF-like recognition
sequences (Figure 2-8). The boundaries of this region match
the DNase I footprint of site I determined 
in vivo (157)
(Figure 2-6). Footprint analysis of the independent binding
events within site I is possible by using the site-directed
mutants described above. Mutation 1, which abolished binding
of HiNF-E, produced a footprint of reduced size (-108 to
-87 bp) that was aligned over the Sp1 recognition site. The
boundary on the proximal side was unchanged while the distal
side was reduced by 14 nucleotides and excluded the ATF
consensus binding site. Mutation 2 abolished the Sp1
consensus site and also produced a reduced size footprint.
This footprint was unaltered on the distal side (-122 bp)
but was withdrawn on the proximal side up to nucleotide
-104. The footprint for HiNF-E was 19 nucleotides long and
aligned over the ATF consensus similarity sequence.
The affinity of the HiNF-E interaction as measured by
the intensity of DNase I cleavage pattern was substantially
reduced by the mutation that abolished HiNF-C binding,
even
though the HiNF-E footprint clearly does not extend to the
site of the Sp1 mutation. HiNF-E binding affinity was
Figure 2-8. DNase I foot rint of site I rotein factors:
HiNF-E and HiNF-C. Amounts of nuclear protein extract
present in the reaction are indicated above each lane.
Boundaries of the footprints are indicated along the side
and Figure 2-6. Mutations are those shown in Figure 2-6.
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reduced greater than 60% by the loss of HiNF-C binding.
However, no effect on the strength of the HiNF-C interaction
was observed by the mutation elimi ating the ATF recognition
site. This finding suggests that the affinity of the HiNF-E
factor for site I is strengthened by the prior binding of
HiNF-C to its adj acent recognition sequence. Thus,
HiNF-CjSp1 may play a dual role in this promoter; first as a
general transcription factor stimulating transcription and
secondly by stabilizing the adjacent binding of a second
transcription factor, HiNF-E.
HiNF-E and HiNF-C are the functional com onents of
site I. To demonstrate that HiNF-E and HiNF-C are
responsible for the stimulation of transcription exerted by
site I, we analyzed the competence of the site-directed
mutant constructs to support cell free transcription of the
, i H4 histone gene. The results shown in Figure 2-9 indicate
that both HiNF-E and HiNF-C binding sequences contribute to
the level of transcription. Elimination of either binding
site interaction reduced transcription initiation
approximately 2 fold. This evidence confirms that site I can
be divided into two functional domains and that HiNF-E and
HiNF-C are the protein components mediating the activation
of transcription.
Figure 2-9. Effect of mutations on cell free transcri tion.
comparison of the promoter activity from the wild type H4
histone promoter (KUC8) (lane 1) and KUC8 constructs
containing the HiNF-E (lane 2) and HiNF-C (lane 3) binding
site mutations. Cell free transcription was performed as in
Figure 2-3. Arrowhead indicates the accurately initiated
transcripts.
cap site
HiNF-E is a novel ATF-like factor with a molecular mass
of 84 kDa. The requirement for an intact ATF recognition
sequence for HiNF-E binding to site I raised the possibility
that HiNF-E is a member of the ATF transcription factor
family (82, 216). In order to address the relationship of
HiNF-E to previouslY identified ATF transcription 
factors,
we determined the molecular mass by UV cross 
linking. A
uniformly labeled HiNF-E binding site probe 
,containing
bromodeoxyuridi was covalently attached to the HiNF-E
factor by treatment with UV light follwed by DNase I
digestio of the excess DNA and resolution by SDS
polyacrylamide gel electrophoresis. The results shown in
Figure 2-10 indicate that the primary protein interacting
with distal site I is of approximatelY 
84 kDa. other
proteins of approximatelY 43 - 45 kDa are also detected
after 60 minutes of UV treatment. All of the bands detected
were dependent on the addition of nuclear extract and
treatment with UV and could be eliminated by digestion with
Proteinase K. This demonstrates that all of the resolved
bands consist of protein cross linked to DNA and not probe
contaminatio . competitio with the distal site I
oligonucleotide specifically eliminated the 84 kDa band
while only minimally decreasing the signal of the 43 -
45 kDa bands. A non-specific oligonucleotide consisting of
Sp1 consensus recognition sequences (Figure 
2-10) or random
Figure 2-10. Molecular wei ht determination of HiNF-E b
cross linkin indicates HiNF-E is 84 kDa. UV cross linking
to site I was performed with BrdU-substituted, uniformly
labeled site I DNA probes. After DNase I digestion the
samples were resolved on a 10% SDS-polyacrylamide gel and
autoradiographed. Length of UV treatment is indicated above
each lane. Specific competitor, DS-I; non-specific
competitor, H3-DSII; Prot. K indicates sample was digested
wi th Proteinase K prior to electrophoresis.
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pUC19 fragments (data not shown) generally lowered the
signal but did not specifically compete any of the bands.
Interestingly, the size of the weakly competed bands is
approximately the size of previously described ATF factors,
43 - 45 kDa (97, 127, 145) and indicates that these ATF
factors have some affinity for distal site I. These results
suggest that an 84 kDa protein is preferentially interacting
at the HiNF-E binding site and because HiNF-E has been
demonstrated to require an ATF consensus sequence for
binding, we define HiNF-E to be a novel member of the ATF
transcription factor family and term it ATF-84.
Selective Purification of ATF-84 b DNA Affinit
Chromato In order to confirm the presence of an 84
kDa protein interacting at site I and to initiate the
physical characterization of ATF-84 we partially purified
the HiNF-E binding activity. Because previous studies have
shown HeLa cells to contain several ATF factors in addition
to ATF-84 we required a method of purification which could
discriminate between these factors. Typical DNA affinity
chromatography involves the synthesis and coupling of double
stranded oligonucleotides containing mul timers of the
binding site to a stationary support. This method has been
used successfully by several groups to purify the more
abundant 43 - 47 kDa ATF factors (83, 145). Therefore in
order to selectively purify ATF-84 we utilized the high
binding affinity of site I for ATF-84 to capture this
protein. Crude HeLa nuclear extract was incubated with
biotin labeled site I DNA probe under the same conditions as
used in the gel mobility shift assay. The protein-DNA
complex was then separated from the excess proteins by
forming a biotin-streptavidin precipitatable super-complex
and followed by elution of the purified protein. The results
shown in Figure 2-11 indicate that this procedure
selectively purified approximately equal amounts of both the
84 kDa and the 45 kDa proteins. This purified preparation
was tested for the presence of HiNF-E binding activity. Gel
mobility shift analysis using the site I probe detects a
protein-DNA complex co-migrating with the HiNF-E/ATF-84
interaction from crude nuclear extracts (Figure 2-12).
Furthermore, competition with either excess distal site I
sequences or consensus ATF sequences specifically blocked
the formation of the HiNF-E interaction. An additional
faster migrating complex was also detected in the purified
preparation, however, this band is apparently unrelated to
the HiNF-E interaction as it was not competed by any of the
oligonucleotides. The level of HiNF-E binding activity in
the purified preparation was less than expected for the
amount of 84 kDa protein dectected on the silver stained
gel. This suggests that during purifcation ATF-84 binding
activity is lost perhaps due to modifications to the protein
Figure 2-11. Biotin stre tavidin affinity Durification of
roteins bindin to site I of the H4 Histone Gene. Hela
cell nuclear extracts were bound to a 16-biotin-UTP-
substituted H4 site I probe in the presence of non-specific
competitor poly (dI-dC). The protein/DNA complexes were
isolated and the specifically bound proteins were eluted and
electrophoresed on a 10% SDS-PAGE. Silver stain detection
of proteins. Lane 1, MW markers; 2, crude Hela cell nuclear
extract; 3 , affinity purified protein. Prominent purified
bands of molecular weight 40 and 80 kD are indicated.
Proteins of 40 - 47 kD size are known to bind to consensus
ATP sites. The 80 kD band is in about the same molecular
weight as estimated by UV cross linking of crude extract
with site I.
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Fiqure 2-12. HiNF-E bindin activit is resent in the
urified rotein aration. Gel mobility shift analysis of
the DNA affinity purified protein preparation with site 
Lanes 1 - 2, crude nuclear extract; Lanes 3 - 7, increasing
amounts of purified protein; Lanes 8 - 11, oligonucleotide
competition, 8 - distal site I oligo, 9 - consensus dimer
Sp1 oligo, 10 -consensus ATF' oligo (CATX3, 82), 11 - ATF
site from the E4 promoter (pE427X1, 81). Lanes 3 - 11 were
exposed 6 times longer than Lanes 1 and 
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or due to separation from an essential 
component. To assess
the physical relationship between ATF-84 and other ATF
family members, weexamined their immunochemical cross-
, .
reactivity. Previous studies have shown that antiserum
prepared against either the ATF-43/47 factors or the APl
transcription factors detect proteins from both families due
to the strong similarities in the leucine zipper and DNA
recognition domains (83). We obtained both ATF-43/47 and API
antiserum (a gift of Dr. M. Green) and utilized them to
detect proteins in the ATF-84 purified preparati . Several
bands were detected on a Western blot of the purified
fraction (Figure 2-13). These included proteins in the size
range of 84 and 47 kDa which were seen in the silver stained
gel and several other bands which were not detectable by
silver staining. While this blot does not provide definitive
proof that the 84 kDa band is immunochemically related to
ATF-43/47 it is very suggestive of 
this. Interestingly, the
antiserum interacted with the band corresponding to ATF-84
very weakly as compared to the other bands suggesting that
while ATF-84 is an ATF consensus site recognition protein
and thus an ATF family member its structure has diverged
sUbstantially from the more common 43 - 47 kDa ATF
transcription factors.
Figure 2-13. Western blot anal sis of artiall v Durified
extracts. Proteins were blotted to Immobilon and incubated
with rabbit antiserum directed to the leucine-zipper region
of API (antisera were generously provided by Dr. Michael
Green). The blots were then treated with alkaline
phosphatase conjugated Ig G antiserum and the protein
patterns were detected with NBT/BCIP The 84 - 90 kD protein
and the 43 - 47 kDa protein of the partially purified
extract is recognized by the antisera directed against the
leucine-zipper.
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Discussion
The F0108 human H4 histone gene contains two regions of
in vivo protein-DNA contact, site I and II, located within
the first 200 base pairs upstream of the transcription
initiation site (157). The site II binding factors described
previously (202) consist of the proliferation-specific, cell
cycle regulated transcription factor HiNF-D and a TATA box
binding factor. The results presented in this report
characterize the interactions at site I and contribute to
the structural understanding of this histone gene proximal
promoter.
site I (-124 to -90 bp ) is a bipartite element
consisting of the proximal and distal binding sites HiNF-C
and HiNF-E, respectively. The HiNF-E binding site contains a
,1,
sequence with strong similarity to the ATF consensus
recognition element, 5'-GTGACGT\A -3' (127), and mutations
of this consensus in the histone promoter reduce the level
of transcription approximately 50%. The ATF sequence has
been identified in several cellular and adenovirus gene
promoters and is referred to as both ATF and CREB (cAMP
responsive element) (127, 146). A number of protein-DNA
binding activities have been described which interact with
this sequence and the factors have been implicated in the
induction of transcription by E1A (119), cAMP (145) and Ca
(179). The isolation of several cDNA clones corresponding to
these factors has confirmed that ATF is a large
transcription factor family (69, 82, 94, 130). The unifying
characteristics of the family are the requirement for
binding of at least the pentamer core, SI-TGACG-3' , and the
presence of a leucine zipper motif assumed to be important
for dimerization and DNA binding (216).
ATF transcription factors have shown substantial
heterogenei ty in their molecular mass. The originally
characterized ATF and CREB factors were of 43 to 47 kDa
(97, 127, 145): however, recently additional mammalian and
rodent factors binding to the ATF consensus have been
identified with molecular mass of 54. (130), 65 (43), 72
(43), and 120 (4) kDa. Molecular mass determination by UV
cross linking measured HiNF-E to be 84 kDa. It is unlikely
that this represents a dimer of the 43 to 47 kDa forms since
similar UV cross linking studies with the adenovirus E4
promoter detected an ATF factor of 45 kDa (127). In
addition, we purified HiNF-E by DNA affinity chromatography
and have shown by western blot analysis that HiNF-E reacts
to some extent with antibodies prepared to ATF-43/47 (a gift
of Dr. Michael Green). Thus , we suggest that HiNF-E is a
novel member of the ATF transcription factor family and term
it ATF-84.
, .
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It is intriguing that the H4 histone promoter
preferentially binds ATF-84 and not the previously
characterized ATF factors even though extracts from the same
cell type as used in these experiments have been shown to
contain 43 - 47 and 120 kDa ATF factors (4,
83). Andrisani
et al. (4) initially co-purified an 80 kDa protein along
with the 120 kDa ATF factor but were unable to detect
sequence specific binding to the ATF consensus 
site. Thus,
the flanking sequences of the HiNF-E binding site may define
the affinity of this site for the ATF-84 
factor. In
addi tion, other factors present in the histone H4 proximal
promoter may assist in the selective binding of 
ATF-84.
As yet it is not clear why ATF-84, but not other ATF
factors is required in this H4 histone 
promoter. Notably,
the ST519 human H3 histone gene promoter also contains an
ATF consensus sequence element that is involved in protein-
DNA interactions both 
in vivo and in vitro 
(156 and A.
van Wijnen, personal communication). No other histone gene
has been described to bind ATF, however, a search of the
published histone gene sequences reveals that a number of
these promoters contain potential ATF binding 
sites. It will
be important to determine if the ST519 H3 ATF factor and
other histone ATF binding si tes selectively interact with
ATF-84 and thus provide a point to coordinately regulate the
histone gene family.
The HiNF-E/ATF-84 interaction is stabilized by the
binding of HiNF-C adjacent to it. HiNF-C binding
characteristics are indistinguishable from Spl and previous
studies in our laboratory have shown HiNF-C binding to be
dependent on metal ions, in particular Zn
2+ (202). The human
Sp1 transcription factor also displays a metal ion
dependence for DNA binding (106). The conserved (cysteine)2
(histidine)2 repeated motif contained in Sp1 is assumed to
complex with Zn2+ to form a zinc finger DNA binding
structure (reviewed in (109). Furthermore, HiNF-C and Sp1
behave similarly during wheat germ agglutinin affinity
chromatography. Wheat germ agglutinin binds with high
affinity to proteins such as Sp1 which contain
N-acetylglucosamine moieties and can be used to selectively
purify for this proteins (100). Thus HiNF-C and Sp1 are
modified similarly with N-acetylglucosamine moieties
providing further evidence consistent with HiNF-C being
equivalent to Sp1. Sp1 recognition sites were first
described in the SV40 promoter and since have been
identified in many viral and cellular promoters (107).
However, no multiplicity of the Sp1 factor has been
described. Thus, these findings strongly suggest that HiNF-C
and Sp1 are identical. Furthermore, mutation of the binding
site resulted in a 50% drop in the transcription efficiency,
suggesting that HiNF-C/Sp1 is the protein component
mediating the stimulation of transcription by the proximal
half of site I.
In vivo site I is a key element in the expression of
this H4 histone gene, up-regulating transcription
approximately 7 fold. Moreover, a promoter consisting of
only site I and upstream sequences is capable of supporting
significant levels of transcription 
in vivo, in the absence
of a TATA box and the HiNF-D binding site (112). Thus site I
is sufficient for directing the formation of a pre-
initiation complex, while the TATA box sequence in site II
may only be required for site specific initiation. The
HiNF-D interaction which is cell cycle regulated may not be
necessary for the basal level of transcription acti vi ty .
Interestingly, recent reports have demonstrated that ATF
interacts directly with TFIID, the TATA box binding 
factor,
and facilitates the formation of the pre-initiation complex
(81, 96). This may be the function of ATF-84 in this H4
histone gene promoter. Furthermore, ATF-84 may function to
position TFIID in the absence of the TATA box sequence as
described for the site II deleted promoter construct. This
may be a mechanism by which naturally occurring RNA
polymerase II, TATA-less promoters assemble the
pre-initiati complex.
In conclusion, the proximal promoter of the F0108 human
H4 histone gene displays a complex architecture in which the
factors stimulate transcription both directly by interaction
with the basic initiation factors and indirectly by
interacting with other transcription factors to stabilize
their association with the promoter.
CHAPTER 3
DISTALLY LOCATED ACTIVATORS AN REPRESSORS MODULATE
HUM H4 HISTONE GENE TRASCRIPTION 
A STRUCTURAL AN FUNCTIONAL STUDY
Abstract
The extent to which distal promoter sequences
contribute to H4 histone gene transcription was examined and
the protein-DNA interactions involved were identified. 
vivo and cell free transcription analysis of a series of 
deletion mutants of the F0108 human H4 histone gene promoter
identified two strong activator elements located at -418 to
-213 bp (near-distal activator) and -730 to -589 bp (far-
distal activator) as well as two potential repressor
elements whose detection was assay dependent. The far-distal
activator stimulates transcription approximately ten fold
and is involved in the formation of three protein-DNA
interactions, H4UA-2, -3, and -4 (Histone H Qpstream
Activator). H4UA-2 requires an intact ATF consensus
recognition sequence for binding and can be competed by
other unrelated ATF binding sites. site directed base
substitution of the H4UA-2 binding site resulted in a two
fold drop in the transcription initiation rate. Thus, these
data strongly suggest that H4UA-2 is a member of the ATF
transcription factor family. Molecular mass analysis has
indicated that the H4UA-2 recognition sequence
preferentially binds an 84 kDa factor but has only limited
affinity for the originally characterized 43-47 kDa ATF
factors. An ATF-84 factor has been previously shown to
interact with the proximal promoter of this H4 histone gene,
suggesting the possibility that a single member of the ATF
transcription factor family might be associated with the
histone gene promoter. H4UA-3 and H4UA-4 interact adjacent
to H4UA-2 at novel recognition sequences. The near-distal
activator stimulated transcription greater than two 
fold.
Protein-DNA interaction mapping of this region identified a
single complex, H4UA-1, with a recognition sequence
characterized by similarity to both the NF1/CTF recognition
consensus and the thyroid hormone response element. These
studies demonstrate a complex modular structure of the human
H4 histone gene promoter, consistent with the requirement of
histone expression to be responsive to alterations in cell
growth.
' '
Introduction
Histone genes encode a set of structural proteins
stringently required for the packaging of newly replicated
DNA into chromatin (31, 98). The human histone genes
constitute a heterogenous, multi-copy family arranged as
clusters of core histone genes (H2A, H2B, H3, H4) or core
with Hl histone genes located on at least three different
chromosomes (29, 76, 90, 125, 133, 181, 200, 217). Expression of
the major class of histone genes, replication dependent
genes, is tightly coupled to DNA synthesis , exhibiting a
20 - 100 fold increase in expression during S-phase
(178, 195). The stimulation of replication dependent
expression is mediated at both the post-transcriptional and
transcriptional levels. The post-transcriptional regulation
is accounted for by an increase in histone mRA stability
during DNA replication and a selective and rapid degradation
of the mRA at the completion of S phase or following
inhibition of DNA synthesis (6, 14, 48, 51, 89, 160). The
transcriptional component of the cell-cycle regulation is a
2 - 5 fold induction of transcription above the consti 
tuti ve
basal level during the initial period of DNA synthesis
(14, 89, 160). This stimulation of transcription is
accompanied by alterations in the chromatin structure and
nucleosomal organization in the promoter region (37, 147).
Promoter sequence elements required for the accurate
initiation of transcription have been identified within the
first 213 base pairs of the replication dependent F0108
human H4 histone gene (157, 202), and Chapter 2 of this
thesis). The proximal promoter contains two regions of
in vivo protein-DNA contact, site I and II (157). site II,
which interacts in vitro 
with factor HiNF-D, consists of the
TATA box and the highly conserved histone specific element
(202). occupancy of this site 
in vivo and in vitro has been
correlated with rendering the gene transcribable in
proliferating cells (193). site I is positioned 26 base
pairs upstream of site II and is required to achieve the
high level of transcription detected from this histone gene
(112), and Chapter 2 of this thesis). site I consists of two
in vitro protein-DNA binding sites, HiNF-E and HiNF-C 
(202),
and Chapter 2 of this thesis). HiNF-E contains an ATF
transcription factor recognition sequence and binds a novel
member of the ATF family termed ATF-84. HiNF-C binds an Sp1
transcription factor whose binding activity stabilizes the
interaction of ATF-84 adjacent to it.
Distal promoter elements have also been suggested to
play a role in transcription of this histone gene.
Kroeger et a 7 demonstrated that the addition of sequences
from -213 to -418 base pairs to the proximal promoter
, !
resul ted in a 10 fold stimulation of transcription (112).
Addi tionally, a sequence element located 6. 5 kB upstream of
the initiation site ha1; been proposed to function as an
enhancer (91). However, we have a poor understanding of the
role these or other distally located elements might play in
regulating histone gene transcription. In this study we have
examined the F0108 human H4 histone gene promoter and
defined a series of activator and repressor sequence
elements located between -231 and -1038 base pairs.
Furthermore, we have identified and partially characterized
the trans-acting protein factors responsible for mediating
the activator effects.
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Materials and Methods
Promoter constructs. The FOI08 human H4 histone
promoter is numbered from the transcription initiation 
site.
promoter deletion constructs (Figure 3-1) were prepared
according to standard cloning procedures. F0005 and F0108A
have been described previously (112). F0002 was constructed
from the original AHHG41 phage clone isolated by
sierra et a7. (181) and F0007 is a sub-clone of F0002
derived by partial EcoRI digestion. F0002D1 was constructed
by partial DraI digestion of the PstI fragment of F0002
followed by isolation of the histone gene containing 2.
16 kB
DraI/PstI fragment and cloning into a pUC19 vector. F0002E9
was constructed similarly by partial Eco0109 digestion of
the XbaI fragment of F0002 followed by isolation of the
histone gene containing 1. 63 kB Eco0109/XbaI fragment and
cloning into a pUC19 vector. FOOOI is an internal deletion
of the EcoRI fragment (-213 to -589 bp) and was generated by
fusing the 2. 7 kB EcoRI fragment (-3300 to -589 bp) of F0003
(112) to the 5' EcoRI site (-213 bp) of F0108A in the
original orientation. F0108X is a 3' deletion of F0108A
constructed by removal of the 770 bp XbaI/HindIII fragment
by digestion with the indicated restriction enzymes and
circularization.
101
Construction of stable cell lines and short-term
transient ex ression. In vivo expression studies were
performed by Dr. Paul Kroeger. Stable cell lines were
established by cotransfection of C127 mouse cells with 10 
of the indicated histone construct and 10 
g of pSV2neo
(190) by the CaP04 precipitate/glycerol shock method (70, 72)
followed by selection for neomycin resistance with Geneticin
(G418, Gibco) (190). The integrated copy number of the human
histone gene construct was measured by preparation of
genomic DNA followed by Southern Blot analysis (189).
Densitometric quantitation of the human histone gene was
normalized to the mouse 18S ribosomal gene. Transfections
for short-term transient expression analysis were performed
as described above except that the pSV2neo plasmid was not
included. The cells were harvested 36 - 48 hours after
glycerol shock. Total cellular RNA was prepared from both
the stable cell lines and the short-term transient
transfection as previously described (19 159) and assayed by
Sl nuclease protection as described in Chapter 
Pre aration of nuclear extracts. Nuclear extracts were
prepared from 1x109 exponentially growing HeLa S3 cells as
described in Chapter 
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In vitro transcri tion. Transcription from covalently
closed circular template DNA was performed as described in
Chapter 2.
Gel mobilit shift anal sis. The gel mobility shift
analysis was performed as described in Chapter 2 except 3 
of poly (dI-dC) . (dI-dC) was used as the non-specific
competi tor and the radioactive probes spanned from -418 to
-213 bp (near-distal activator) and -730 to -589 bp (far-
distal activator). synthetic oligonucleotides were all used
at 500 fold molar excess. The ATF-84 oligonucleotide has
been described in Chapter 2 and is referred to therein as
the distal site I oligonucleotide. The consensus Sp1 dimer
recognition site oligonucleotide has been described
previously (206). The H4UA-2 oligonucleotide is:
5' -GATCTGGGATTCGCTGACGTCCATGAGAAG-3 .
3 ' -ACCCTAAGCGACTGCAGGTACTCTTTCCTAG-5 '
Meth lation interference and meth lation rotection.
Methylation interference was performed essentially as
described by staudt et a7. (192) except that the entire
preparative gel mobility shift gel was electrotransferred to
NA45 DEAE membrane (Schleicher & Schuell) as described by
singh et a7. (183). The probes used were as described for
the gel mobility shift assay and were partially methylated
by a 5 minute 22 C treatment with 1 l of dimethylsulfate
(DMS, Kodak) in a 200 l reaction volume containing 50 ro
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Na-cacodylate (pH 8. 0) and 1 ro EDTA. The reaction was
stopped by the addition of 4 l of DMS stop buffer (1. 5 M
Na-acetate (pH 7. 0), 1 M p-mercaptoethanol), 10 g yeast
t-RNA, and 600 l ethanol and immediately placing the
reaction tube in a dry ice-ethanol bath. The DNA was
pelleted, resuspended in 250 l of 0. 3 M Na-acetate and
precipitated again with 3 volumes of ethanol. The
precipitation was repeated for a third time and the DNA was
resuspended and subjected to a standard gel mobility shift
assay. After electrophoresis the entire gel was
electrophoretically transferred to DEAE membrane (NA45
Schleicher & Schuell) at 200 mA for 2 hours at 4 C. The blot
was then autoradiographed and the regions corresponding to
the free and bound DNA were isolated and the DNA eluted with
200 l of a solution of 1. 0 M NaCl, 0. 1 ro EDTA , and 20 ro
Tris-HCl (pH 8. 0) at 68 C for 45 minutes. The DNA was
precipitated, resuspended in 100 l of 10% piperidine and
incubated for 30 minutes at 90 C. The reaction was then
lyophilized and serially resuspended in 50 and 25 
l H 0 and
lyophilized to dryness each time. The samples were then
resolved on an 8% polyacrylamide gel as described for the Sl
protection analysis (Chapter 2). Methylation protection of
the same probes as used in the methylation interference
assay was performed as described previously (9). Binding
reactions were as described for the DNase I protection and
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followed by treatment of the reactions with 0. 5% final DMS
for 45 seconds at 22 C. The reactions were stopped with
2 J.l DMS stop buffer and 48 J.l ethanol and iriediately
placed in a dry ice-ethanol bath. The DNA was precipitated
twice followed by piperidine treatment and electrophoresis
as described above.
site-directed muta enesis. Selected base substitutions
were introduced into the promoter of the H4 histone gene by
oligonucleotide directed mutagenesis without phenotypic
selection, as described in Chapter 2. Uracil containing
single strand M13 DNA carrying the 834 bp BamHI/SmaI
promoter fragment from F0002 was prepared by amplification
in the E. coli strain CJ236 (dut - ung ) (a gift of
Dr. Barbara Bachmann, E. co 1 i Genetic stock Center, Yale
University). Mutations were introduced in complementary
synthetic oligonucleotides containing the base substitutions
in the H4UA-2 binding site:
5' -GGGATTCGCTGAtcTCCATGAG-3'
" '
The mutations were recovered by transfection into wild type
E. coli strain XLI-Blue (stratagene) and were confirmed by
enzymatic sequencing (sequenase , US Biochemical). The
mutated 834 bp BamHI/SmaI promoter containing fragment was
cloned back into F0002 to generate F0002 NMP.
'" 
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DNase I rotection. DNase I footprinting was performed
as described in Chapter 
uv cross-linkin of nuclear roteins. ' Molecular mass
determination by UV cross-linking was performed as described
in Chapter 2 except the probe contained the entire far-
distal activator region (-730 to -589 bp).
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Results
The human H4 histone gene F0108 contains at least three
transcriptional regulatory elements in the proximal promoter
region which have been described previously
(112, 157, 202) , and Chapter 2 of this thesis), and additional
elements located further upstream in the distal promoter
(112). To address the function and structure of the distal
promoter we have scanned the region with a detailed set of
5' deletion mutants for activators or repressors of
transcription and subsequently have investigated the
protein-DNA interactions involved in the activator domains.
Transcri tion anal sis of 5' deletion mutants.
created a series of six 5' promoter deletion constructs
encompassing the region from -213 bp to -1038 bp which
divided the distal promoter into 150 - 200 base pair
segments (Figure 3-1). Each construct was subsequently
assayed for efficiency of transcription both 
in vitro and
in vivo. Transcription 
in vitro was performed in a cell free
transcription system utilizing supercoiled DNA templates and
HeLa S3 nuclear extracts which was shown previously to
support accurate transcription initiation from this histone
H4 proximal promoter (-213 bp) (38, 190). In vivo expression
was measured after transfection of the constructs into C127
Fiqure 3-1. Schematic re resentation of the human H4
histone ene distal romoter 5' deletion mutants.
Construction of the deletions is detailed in the Materials
and Methods. Shaded box represents the location of the
histone gene transcribed region and arrow indicates the
direction of transcription. Symols for restriction
endonuclease sites: BamBI; D DraI; . , Eco0109;
o , EcoRI; . , HindIII; . , XbaI; . , PstI.
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or LTK- mouse cells as either short-term transient
expression or as stably integrated cell 
lines. The resultant
transcripts from both the 
in vitro and in vivo experiments
were assayed by Sl nuclease protection.
In vivo transcription analysis of the region between
-418 bp and -213 bp with both transient expression assays
and cell lines containing stably integrated constructs
identified a positive element within these 205 nucleotides.
Addition of the -418 to -213 bp sequences 
(F0005) to the
proximal promoter (F0108X or F0108A) resulted in a 2.
5 -
4 fold higher expression in stable cell 
lines, while
addi tion of 3' flanking sequences had no effect on
expression (F0108X ys F0108A) (Table 3-1). In all cases
results for the stable cell lines were corrected for the
number of copies per cell. Furthermore, transient expression
experiments in both C127 and LTK- mouse 
cells showed that
addition of the -418 to -213 sequences resulted in
expression above proximal promoter levels 
(F0108A) (Figure
3-2, Table 3-1). The stimulatory nature of these sequences
was further confirmed by cell free transcription analysis.
Addition of this element (F0005 vs F0108X) increased the
rate of cell free transcription initiation two fold above
that of the proximal promoter (Figure 3-3 and Table 3-1),
al though data from the F0005 construct were variable and
Table 3-1. Transcri tional activit of the human H4 histone
ene distal romoter deletion constructs. Values represent
the average of at least five independent experiments. Levels
of transcription in the stable cell lines has been
normalized for the copy number. ND - no data.
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Fiqure 3-2. ression of the histone romoter deletion
constructs in transientl transfected C127 and LTK- mouse
cells. Total cellular RNA was isolated and assayed by Sl
nuclease protection. Arrows indicate the location of the
accurately initiated transcripts of the transfected human H4
histone gene and the endogenous mouse H4 histone gene. The
construct transfected is indicated above each lane. HeLa
control human RNA; C127 and LTK- control untransfected mouse
cell RNA.
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Figure 3-3. Cell free transcri tion anal sis of the H4
histone romoter deletions. Supercoiled plasmids containing
the series of distal promoter deletion mutants was
transcribed in a HeLa nuclear extract system and transcripts
were assayed by Sl nuclease protection. Arrow indicates the
accurately initiated transcripts. Lanes: 1, F0002; 2
F0002Dl; 3 , F0002E9; 4, F0007; S, FOODS; 6, FOI08X;
, F0001.
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inconclusive after statistical analysis. The combination of
each of these expression studies clearly indicates that this
region has a stimulatory effect on transcription and it has
been termed the near-distal activator.
The next deletion mutant, F0007, includes an addi tional
171 base pairs up to -589 bp. This region represses
transcription in vitro 5 fold below the proximal promoter
rate (F0108X) but interestingly does not have a significant
effect in vivo (Figures 3-2 and 3-3, Table 3-1). The
difference may imply species specificity for the repressor
since the in vivo experiments are performed in mouse cells
while the in vitro experiments use nuclear extracts from
human cells. It is also possible that differences in the
structure of the DNA template or association of the DNA with
structural elements in vivo may affect the interaction and
availability of specific factors which contribute to the
repressor activity.
A second activator region was identified between -730
bp (F0002E9) and -589 bp (F0007). A comparison of the cell
free transcription initiation rate reveals F0002E9 is
greater than 10 fold more active than F0007 (Figure 3-3,
Table 3-1). This is the strongest activator detected in the
histone promoter and has been termed the far-distal
activator. This 141 base pair region is able to overcome
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fully the repression of F0007 in vitro and stimulates
transcription 2. 3 fold above the proximal promoter (F0108X).
Two additional constructs, F0002D1 (-926 bp) and F0002
(-1038 bp), are indistinguishable from F0002E9 
transcription efficiency. The function of the far-distal
activator was further demonstrated by construction of an
internal deletion which positions the activator adjacent to
the proximal promoter. This construct, F0001, displayed the
highest level of transcription in vitro of any construct
tested, 3. 5 fold higher than the proximal promoter alone.
The far-distal activator is also highly active in vivo.
Transient expression of F0002E9 (-930 bp) was 2. 3 fold
higher than the next smaller construct , F0007 (-589 bp)
(Figure 3-2). The absence of a repressor activity in vivo 
F0007 allows for a cumulative effect of the near-distal
activator and the far-distal activator. This is revealed by
an approximately 40 fold stimulation of expression of
F0002E9 as compared to F0108A (Table 3-1). Interestingly,
additional sequences contained in F0002D1 (-926 bp), which
had no effect in vitro were able to repress transcription
substantially in vivo. This result is supported by the
expression of the internal deletion construct , F0001 , which
is missing the near-distal activator (-418 to -213 bp) and
thus has the far-distal activator and the in vivo repressor
I '
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posi tioned upstream of the proximal promoter; the result is
a poorly expressing construct. Furthermore, stable cell
lines of F0002 containing the entire promoter up to -1038 bp
expressed at a lower level than F0005 (-418 bp), indicating
that the activity in vivo 
of the far-distal activator can be
masked by sequences upstream from it or perhaps is
functionally linked to the adjacent sequences.
Mul ti le rotein-DNA interactions in the far-distal
activator element. To address the molecular mechanisms
mediating the transcriptional contribution of the far-distal
activator element (-730 to -589 bp), we systematically
investigated the number and characteristics of the protein-
DNA interactions involved in this region. Initial
characterization by the gel mobility shift assay identified
two strong interactions, Histone H Qpstream Activator - 2
(H4UA-2) and H4UA-3, and one weak interaction H4UA-4
(Figure 3-4). H4UA-2 and H4UA-3 were equally represented at
low nuclear extract concentrations, 50ng/ 
l, while H4 UA-4
was detectable only at high concentrations, 200 ng/ l. The
binding site regions were localized within the far-distal
activator by bi-directional deletion analysis combined with
the gel mobility shift assay (Figure 3-5A and 3-5B). In this
technique the full length fragment is radiolabeled at one
Figure 3-4. Gel mobilit shift anal sis of the far-distal
activator re ion detects three rotein-DNA interactions
H4UA-2 -4. A radiolabeled BanII/EcoRI probe (-730 to
-589 bp) was incubated with increasing concentrations (0.
to 8 g) of HeLa nuclear extract and resolved on a
polyacrylamide gel as described previously (192).
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Figure 3-5. Bi-directional deletion anal sis of the far-
distal activator re ion defines the location of H4UA-2
-4. A) Autoradiograph of gel mobility shift assay
performed with a series of progressively shortened probes.
Probes used are indicated at the side and the symols used
are: H4UA-2; . , H4UA-3; . , H4UA-4. B) Schematic
representation of the bi -directional deletion probes and
resul ts. Hatched ovals indicate approximate positions of the
protein-DNA interactions.
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end and then cleaved with the appropriate restriction
enzymes to produce a series of progressively shorter
radiolabeled fragments. These fragments are subsequently
assayed for protein binding by altered electrophoretic
mobility. Deletions are generated from both ends to define
the maximal 5' and 3 i boundaries of the interaction sites.
H4UA-2 binding activity was maintained as the probe was
deleted from the 5' end (BanII, -730) down to the HinfI
restriction site (-649 bp). Further deletion from the 
5' end
(HindIII) abolished H4UA-2 binding. Deletion from the 
3' end
of the probe to the HindIII restriction site 
(-628 bp)
resulted in a 90% loss of H4UA-2 binding activity.
Additional 3' deletions completely abolished binding. These
results define the maximal boundaries of H4UA-2 to between
-649 bp (HinfI) and -628 bp (HindIII). Because cleavage at
the HindIII restriction site dramatically destabilized the
interaction without abolishing it, the H4UA-2 recognition
sequence is likely to be just upstream of this 
site.
H4UA-2 bindin ires an intact ATF reco
nition site.
The H4UA-2 binding site was confirmed and refined by
determination of the methylation interference 
fingerprint.
In this technique the radiolabeled DNA fragment was treated
wi th DMS prior to the formation of the protein-DNA 
complex.
The free probe and H4UA-l bound probe were separated by the
, '
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gel mobility shift assay and isolated. After treatment
according to the Maxam and Gilbert guanine sequencing
protocol (134) the free and bound DNA are resolved on a 6%
denaturing polyacrylamide gel. The absence of a band in the
bound lane indicates methylation at this guanine residue was
sufficient to block formation of the protein-DNA
interaction. A comparison of the interference patterns of
the free probe and the H4UA-2 bound probe reveals six
guanine contact points (Figure 3-6). The lower strand
contains three closely spaced contacts at -636, -637, and
-640 bp, while the three upper strand contacts extend to
both sides at -633, -639, and -642 bp. Sequence analysis of
this domain identified a region of strong similarity to the
consensus ATF recognition site , 5' -CGTCA-3' (Figure 3-7).
The prototype ATF consensus is an overlapping indirect
repeat of this pentamer and is proposed to be involved in
binding of a dimerized ATF molecule. Each of the guanine
residues ' in this consensus element was implicated as
important for binding of H4UA-2 by the DMS fingerprint.
Furthermore, this fingerprint matches with published
interference patterns for known ATF binding sites (119).
To assess directly the relationship between H4UA-2
binding and the ATF consensus element, we carried out
oligonucleotide competition analysis with an unrelated
consensus ATF recognition site. competition with a 31 bp
Figure 3-6. Meth lation interference anal sis of the H4UA-2
and H4UA-3 interactions. A partially methylated BanII/EcoRI(-730 to -589 bp) probe, uniquely labeled at the 5' end of
the upper or lower strand , was used in the HeLa nuclear
extract binding reactions. Free and H4UA-2 bound or H4UA-3
bound probe were separated by altered electrophoretic
mobility, isolated and analyzed on 8% polyacrylamide
sequencing gels after piperidine cleavage (134). Relative
sequence position is indicated next to the C+T and G
sequencing ladders. Symols: H4UA-2; . , H4UA-3.
lower strand upper strand 127
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-687
Figure 3-7. ence schematic of the far-distal activator
ion. positions of H4UA-2 and H4UA-3 are over-lined,
& marks the guanine methylation interference contact points.
The ATF consensus element is indicated by the overlapping
arrows. The H4UA-2 binding site mutant is defined below.
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synthetic oligomer spanning the H4UA-2 binding domain
effectively competed H4UA-2 binding, as expected (Figure
3-8A), while H4UA-3 binding was unaffected. Sequences
corresponding to a known ATF binding site (ATF-84) from the
proximal promoter of this human H4 histone gene were also
able to compete specifically for H4UA-2 binding although the
ATF-84 oligomer is only related to the H4UA-2 binding domain
in the 5 base pair core ATF recognition sequence. An
unrelated sequence was ineffective as a competitor of either
H4UA-2 or H4UA-3 binding activity. These results suggest
that H4UA-2 binding is directly related to the presence of
an ATF consensus binding site and demonstrate that H4UA-2 is
capable of binding to other ATF consensus elements.
Further evidence supporting the relationship between
H4UA-2 and ATF is derived from studies of site directed
mutants of the binding domain. The ATF consensus sequence
was disrupted by a two base pair substitution using
mismatched oligonucleotide directed mutagenesis
(Figure 3-7). The mutated sequence was subsequently employed
in the gel mobility shift assay to determine the effect on
the protein-DNA interactions (Figure 3-8A). The mutated
probe maintained the H4UA-3 binding activity but was unable
to form any detectable H4UA-2 interactions. These results
demonstrate that H4UA-2 binding requires an intact ATF
Figure 3-8. Com etition and mutation of the H4UA-2 bindinsite. A) Gel mobility shift analysis of the wild type (wt)
and H4UA-2 binding site mutant (mutant) far-distal activator
region probes. Competition was at 500 fold molar excess of
the indicated oligonucleotide: specific, H4UA-2;
nonspecific, H3-DII; ATF-84 , oligonucleotide of the proximal
ATF site in the histone promoter. B) Effect of the H4UA-2
mutation on cell free transcription from the histone
promoter. Transcriptions were performed as in Figure 3-3.
Lane 1, F0002; Lane 2, F0002dNMP. Arrowhead indicates the
accurately initiated transcripts.
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consensus pentamer and confirms a close relationship between
H4UA-2 and ATF.
H4UA-2 is a transcri tional activator. The
availability of the site directed mutant that specifically
abolished H4UA-2 binding activity provided a means of
directly establishing the contribution of H4UA-2 to
transcription. The mutation was placed into the parent
construct F0002 (-1038 bp) to create F0002 NMP. Both of
these constructs were assayed in a cell free transcription
system to measure the relative efficiency of transcription.
The results shown in Figure 3-8B reveal that mutation of the
ATF consensus sequence and therefore elimination of H4UA-2
binding reduced the transcription rate approximately two
fold. These findings strongly suggest that H4UA-2 is at
least one of the protein components mediating the
stimulatory effect of the far-distal activator region.
secondly, this result identifies H4UA-2 as a functional
member of the ATF family of transcription factors.
H4UA-2 and ATF-84 are related. Because this human H4
histone gene contains a second previously identified ATF
binding site located in the proximal promoter 
(-122 to -104
bp), we were interested in determining the relationship
between the two factors. The proximal ATF binding site
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selectively interacts with a novel ATF transcription factor
family member, termed ATF-84, which was identified by its
unique molecular mass, 84 kDa. The molecular mass
determination of H4UA-2 was performed by indirectly
radiolabeling the factor by UV cross-linking the bound
proteins to a uniformly radiolabeled, bromo-deoxyuridine
substi tuted DNA binding site. The unbound DNA sequences were
removed by DNase I digestion and the covalently cross-linked
protein-DNA complexes were resolved on SDS-polyacrylamide
gels.
We used the entire far-distal activator region as the
uv cross-linking probe which will potentially allow for the
detection of H4UA-2, H4UA-3, and H4UA-4. Treatment of the
binding mixture with UV light for up to 60 minutes resulted
in the appearance of several bands from 40 - 130 kDa
(Figure 3-9). Control experiments demonstrated that all of
these bands were dependent on the presence of nuclear
extract and treatment with UV light (data not shown). In
order to define which of the bands were related to H4UA-2
binding, we added a 500 fold molar excess of specific or
non-specific competitor oligomers as described above. The
specific competitor, spanning the H4UA-2 binding domain,
selectively competed the band at 84 kDa and a group of bands
at 40 - 50 kDa. Most ATF factors thus far identified have a
molecular mass in the range of 43 to 47 kDa (97, 127, 145)
Figure 3-9. Molecular wei ht determination of H4UA-2 b
cross linkin detects s ecific roteins at 84 kDa and 40 -
50 kDa. UV cross linking to the far-distal activator was
performed with a BrdU-substituted, uniformly labeled DNA
probe. After DNase I digestion the samples were resolved on
a 10% SDS-polyacrylamide gel and autoradiographed. Length of
UV treatment is indicated above each lane. Specific
competitor, H4UA-2 oligonucleotide: non-specific competitor,
H3-DSII: ATF-84 , oligonucleotide of the additional ATF
binding site in the histone proximal promoter.
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suggesting that the H4UA-2 binding domain is capable of
forming interactions with these ATF factors . Additionally,
the presence of an 84 kDa band that can be competed
specifically indicates H4UA-2 may be related to the histone
H4 promoter factor, ATF-84. Competi tion with the highly
selective ATF-84 binding site oligomer specifically
abolished the 84 kDa band while only partially affecting the
interactions in the 40 to 50 kDa range. A non-specific
competitor consisting of a dimerized Sp1 binding site had no
effect on the 84 kDa band but did significantly reduce the
signal at 40 to 50 kDa. This may signify that the 40 to
50 kDa bands are either very weak ATF interactions with the
H4UA-2 binding domain or that these bands are non-specific
interactions with probe. Thus , these results indicate that
H4UA-2 is a member of the ATF transcription factor family
and that its binding domain has preferential affinity for
the histone H4 ATF-84 transcription factor and weak affinity
for the common ATF factors (43 - 47 kDa).
Anal sis of H4UA-3 and H4UA-4 reco ni tion ences.
Analysis of the remainder of the far-distal activator has
defined the binding domains for H4UA-3 and H4UA-4. The
H4UA-3 protein-DNA interaction mapped to the upstream side
of H4UA-2 by bi-directional deletion analysis (Figure 3-5A
and 3-5B). H4UA-3 binding activity was abolished by either
139
5' or 3' deletion of the fragment between the MboII and
HinfI restriction sites. H4UA-4 binding was detectable with
even the largest 3' dHletion (BanII-MboII probe) and
conversely was abolished with the first deletion from the 
end (MnlI-EcoRI probe). Thus these results demonstrate that
H4UA-3 lies between -691 and -649 bp (MboII to HinfI) and
that H4UA-4 is positioned between -730 and -691 bp (BanII to
MboII). Moreover, H4UA-4 requires sequences overlapping or
5' of the MnlI site (-708 bp).
The sequence requirements for H4UA-3 binding were
determined through an analysis of the methylation
interference pattern (Figure 3-6). six guanine residues
located 16 base pairs upstream of the H4UA-2 binding site
were found to be in close association with the H4UA-3
protein. The upper strand contact points were at -659, -663,
and -667 bp while the lower strand was in contact at -661,
-664, and -665 bp. These six contacts form a cluster
representing all of the guanine residues in a nine base pair
domain. Extensive search of published binding sites has
revealed no similarity to known transcription factor
recognition sequences. H4UA-4 has eluded further analysis
due to its weak interaction with this probe.
Protein-DNA interactions in the near-distal activator
element. Investigation of the structural components of the
Figure 3-10. Resolution of onl one rotein-DNAinteraction H4UA-1 in the near-distal activator re ion.
Gel mobility shift analysis of the entire HindIII/EcoRI
(-418 to -213 bp) DNA fragment with increasing amounts of
HeLa nuclear extract (0. 5 - 8 
g).
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Figure 3-11. Bi-directional deletion anal sis of the near-
distal activator re ion defines the location of H4UA-1. 
Autoradiograph of gel mobility shift assay performed with a
series of progressively shortened probes. Probes used are
indicated at the side and the arrowheads indicates the H4UA-1 complex. B) Schematic representation of the bi-
directional deletion probes and results. Hatched oval
indicates approximate position of the protein-DNAinteraction.
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Nucleotide resolution of the H4UA-1 bindin site.
Mapping of the H4UA-1 interaction to a small segment of the
H4 promoter facilitat(; d a closer determination of the
interaction boundaries by DNase I footprint analysis. Crude
nuclear extract was incubated with a full length
radiolabeled near-distal activator fragment under conditions
which allow formation of the protein-DNA interactions. After
brief treatment with DNase I, the DNA was recovered and
resolved on a 6% denaturing polyacrylamide gel
(Figure 3-12). Comparison of the control lanes (no protein)
to the lanes with increasing amounts of nuclear extract
reveals a 27 nucleotide region protected from DNase I
cleavage. This region spans from -334 to -360 bp on the
upper strand and is positioned within the maximal boundaries
predicted from the bi-directional deletion analysis.
The sequence requirements for the H4UA-1 interaction
were resolved in more detail by an analysis of the guanine
residues in very close contact with the protein. Two DMS
fingerprinting approaches were undertaken simultaneously,
DMS interference and DMS protection. In the first approach
the lower strand displayed five residues which interfered
with binding of H4UA-1 , -332, -338 , -339 , -341, and -342 bp,
while the upper strand contained only one contact at -344 bp
(Figure 3-13). Interestingly, all six of these methylation
interference sites lie in the 3' half of the H4UA-1
Figure 3-12. DNase I foot rint of the H4UA-1 interaction.
The HindIII/EcoRI (-418 to -213 bp) probe was uniquely
labeled at the EcoRI site and incubated with 12, 24 , 36, and
4 8 g of HeLa nuclear extract (lanes 1-4). Control lanes
were incubated with 20 g of BSA. After partial DNase I
digestion the DNA was recovered an analyzed on an 8%
polyacrylamide sequencing gel. The footprint is indicated by
the bar and relative nucleotide numbers.
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Figure 3-13. Meth lation interference and meth lation
rotection of the H4UA-1 interaction. The HindIII/MspI 418
to -278 bp) DNA fragment was uniquely labeled on the 5' end
of either the upper or lower strand. Methylation
interference: Partially methylated probes were incubated
with 6 g of HeLa nuclear extract and free and H4UA-1 bound
probe were separated by altered electrophoretic mObility
followed by piperidine cleavage and analysis on an 8%
polyacrylamide sequencing gel. The points of methylation
interference are indicated by . Methylation protection:
The H4UA-l binding site probes were incubated with nuclear
extract and then partially methylated by DMS. The DNA was
purified and analyzed as above. Lanes: (-), g BSA; (+),
3 6 g of nuclear extract. Filled circles indicate
protections. Open circles indicate enhancements.
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footprint. We also examined the element for additional
guanine contacts that might only be detectable with the
direct DMS protection assay in which the protein-DNA
complexes are formed prior to treatment with DMS. The
results shown in Figure 3-13 indicate several additional
points of DNA contact with H4UA-1. DMS protection of the
lower strand revealed strong protections at -338 and
-339 bp. Furthermore, there is an enhancement of methylation
at -352 bp. The cause of enhancements is not fully
understood but it is bel ieved to be the result of the
protein forming a hydrophobic pocket around the guanine
residue. The pocket stabilizes the very labile DMS molecule
leading to an enhancement of methylation. However, both
protections and enhancements indicate a close association of
the protein with that guanine residue. The upper strand
contains one protection at -350 bp and one enhancement at
-365 bp. The five methylation protections and enhancements
are located throughout the H4UA-1 binding domain. A
compilation of all of the fingerprint data (Figure 3-14) and
an analysis of the sequences wi thin this region reveal two
potential homologies to known transcription factor
recognition sequences. In the distal two thirds of the
DNase I footprint are three copies of the NF1/CTF consensus
recognition sequence , 5' -YTGGCA-3' . Two are arranged in the
typical indirect repeat form while the third is spaced three
Figure 3-14. ence schematic of the near-distal
activator re ion. Guanine residue contact points are
indicated: A , interference: protection:
o , enhancement. Regions of similarity to the NF-1 consensus
recognition sequence are indicated by the dark arrows.
Regions of similarity to the thyroid hormone receptor
binding site are indicated by the open arrows.
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base pairs down stream. This sequence has been shown to be
present in many different viral and cellular promoters and
is functionally important in both transcription and
replication (104). Additionally, there is a potential
thyroid hormone response element consensus sequence. An
imperfect direct repeat encompassing 6 of the 9 guanine
contact points bears striking similarities to the high
affinity thyroid hormone receptor binding site
5' -CTGGAGGT-3' described in the human a-myosin heavy chain
gene promoter (65).
155
Discussion
The functional promoter of the replication dependent
F0108 human H4 histone gene has been shown to extend at
least 1000 base pairs upstream of the initiation site.
Previous studies from this laboratory have defined two
domains within the proximal promoter (-213 to 0 bp); one is
required for site specific transcription initiation and one
has a stimulatory activity (157, 193, 202), and Chapter 2 of
this thesis). In this report we have extended the molecular
characterization of the elements that determine the specific
level of H4 histone gene transcription and the response to a
spectrum of physiological signals.
The far-distal activator region (-730 to -589 bp)
possesses the strongest stimulatory activity detected in
this promoter, increasing the initiation rate greater than
10 fold. Investigation of the protein-DNA interactions
occurring within this region revealed three binding sites,
H4UA-2, H4UA-3 , H4UA-4. Specific elimination of the H4UA-2
binding activity by site directed mutagenesis demonstrated
that H4UA-2 was at least one of the protein components
contributing to the stimulatory acti vi ty of the far-distal
activator as deletion of this binding site resulted in a
greater than 50% drop in transcription. H4UA-2 binds to a
sequence with strong similarity (7/8 match) to the consensus
ATF /CREB recognition site 5' -TGACGTCA-3' . Previously
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described ATF factors have been shown to bind to degenerate
forms of this sequence but the invariant pentamer core
5' -TGACG-3' , is always required (85, 127). site directed
mutagenesis of the pentamer core of the H4UA-2 binding site
completely abolished binding activity, demonstrating that
H4UA-2 is an ATF consensus site binding factor. Many
cellular and viral gene promoters have been shown to contain
ATF consensus binding sites and these sites have been
implicated in mediating induction by adenovirus E1a protein
(119), cyclic AMP (145), and calcium (179). A number of
protein factors have been identified which bind to these
sites. ATF transcription factors have thus far been found in
various eukaryotic tissues and transformed cell lines , yeast
and Xenopus oocytes and have molecular mass spanning from
43 kDa to 120 kDa (4 43, 97, 127, 128, 130, 145, 168) . Multiple
ATF family members have been identified in the same cell,
raising the interesting questions of what is the role of
multiple factors and how are they resolved in vivo.
Furthermore, while it is apparent that these factors have
similar binding characteristics , the function of each
individual ATF factor may be quite distinct (129).
The histone H4 gene promoter we have studied has an
additional ATF transcription factor binding site , HiNF-E,
located wi thin the proximal promoter (see Chapter 2). This
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binding site is more widely divergent from the prototype
consensus than the H4UA-2 binding site but still maintains
the invariant pentamer core. A single ATF factor of
molecular mass 84 kDa preferentially binds to this site.
H4UA-2 also displayed affinity for the ATF-84 factor. ATF-84
has not been detected by other laboratories using HeLa cell
extracts and different promoters; this presents the
intriguing possibility that ATF-84 may be directed
specifically to histone gene promoters. Another ATF binding
site has been localized in the proximal promoter of the
ST519 human H3 histone gene (A. van Wijnen personal
communication). Characterization of the ATF factor binding
to this histone gene may provide additional information on
the nature of ATF-84.
The nuclear matrix contains a factor, NMP-1 , which
exhibits binding characteristics identical to H4UA-2
(Dr. S. Dworetzky personal communication). NMP-1 was
isolated from HeLa cell nuclear matrix prepared by the
double detergent method of Fey et a1 (63) followed by
solubilization in 7. 0 M urea and dialysis back into typical
nuclear extract storage buffer. Gel mobility shift analysis
with the entire far distal activator region detected only
one interaction and localized it to the H4UA-2 binding site.
Fingerprint analysis and site directed mutagenesis
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identified NMP-1 as an ATF family member. However, molecular
mass determination revealed NMP-1 to consist of only 54 and
39 kDa proteins. Thus, H4UA-2 and NMP-1 are apparently
distinct members of the ATF transcription factor family
which compete for binding in the far distal activator
region. It is unclear at this point which factor is binding
to the far distal activator region in vivo or if there is
some sort of switching between the soluble ATF-84 and
attachment to the matrix through NMP-1. Analysis of these
two proteins during changing conditions of histone gene
transcription may begin to provide direct insight into the
relationship between matrix attachment and transcription of
nearby genes. Furthermore, the presence of two additional
soluble transcription factors , H4UA-3 and H4UA-4 , adj acent
to the H4UA-2/NMP-1 binding site suggests a mechanism by
which distally located transcription factors could be
sequestered to stimulate the assembly and activation of the
transcription complex. Tethering of the factors at a matrix
attachment site would provide the structural means to loop
out the intervening DNA sequences between the initiation
complex and the distal activator region and allow the
proteins to come in contact to effect a change in
transcription.
, i
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The F0108 human H4 histone gene contains an additional
positive element located at -213 to -418 base pairs. The
near-distal activator is capable of forming only one strong
protein-DNA interaction, H4UA-l. The DNase I footprint
H4UA-l contains consensus recognition sequences for the
ubiquitous factor NF1/CTF. NF1/CTF has been described to
possess two functions. NFl was originally detected binding
to the origin of replication of adenovirus 2 and shown to be
involved in the initiation of DNA synthesis (80 165). CTF
was identified in several cellular and viral promoters as a
member of the CCAAT box binding factor family which was
involved in the activation of transcription (105 150). A
biochemical analysis of these two factors has suggested that
they are identical (104). Thus , H4UA-1 may be related to
NF1/CTF, however , early studies of this H4 histone gene
promoter demonstrated this region could not function as an
origin of replication (91). It is interesting to note that
while the NF1/CTF recognition elements are toward the distal
side of the footprint the strong DMS interference points lie
to the proximal side of the footprint. Overlapping the
proximal NF1/CTF sites is a recognition sequence for the
thyroid hormone receptor. A consensus thyroid hormone
receptor binding sites has not been well defined, however,
one previously characterized TRE consists of an 8 base pair
imperfect direct repeat in the a-myosin heavy chain gene
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promoter (65). The H4UA-1 binding site contains an 11/16
match with this sequence suggesting the potential to
interact wi th the thyroid hormone receptor. It has been
observed previously that hormone response elements tend to
be clustered with binding sites for other transcription
factors (177). An arrangement such as this with structural
similari ties to the near-distal activator has been described
for the mouse mammary tumor virus promoter. The long
terminal repeats contain adj acent NF1/CTF and hormone
response element binding sites which compete for binding
(26). This could provide a direct mechanism to regulate
histone gene transcription in response to changes in growth
due to hormone induction. Further competition and binding
site mutation studies will be required to sort out the
relationship of H4UA-1 to these factors.
In conclusion we have demonstrated that the histone H4
promoter is a complex modular structure extending at least
1000 base pairs upstream of the initiation site.
Transcription is modulated with respect to a series of
positive and negative elements. The two distally located
activator regions have the potential to interact with
general transcription factors, hormone response elements,
nuclear matrix proteins and two previously uncharacterized
factors.
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CHAPTER 4
MULTIPLE MECHISMS REGULATE THE PROLIFERATION SPECIFIC
HISTONE GENE TRASCRIPTION FACTOR, HINF-D, IN NORML
DIPLOID FIBROBLASTS
Abstract
The proliferation-specific transcription factor
complex, HiNF-D , interacts with sequence specificity in a
proximal promoter element of the human H4 histone gene
F0108, designated site II. The occupancy of Site II by
HiNF-D has been implicated in proper transcription
initiation and as a component of the cell cycle regulation
of this gene. In the present study we have investigated the
role of the HiNF-D/Site II interaction in controlling the
level of H4 hi ,tone gene transcription during modifications
of normal cellular growth. HiNF-D binding activity is
present at high levels in rapidly proliferating cultures of
human diploid fibroblasts and is reduced to less than 2%
upon the cessation of proliferation induced by serum
deprivation of sparsely populated fibroblast cultures.
Density dependent quiescence also abolishes the HiNF-D
binding activity. Down regulation of transcription from the
H4 gene occurs concomitant with the loss of the HiNF-D/site
II interaction , further suggesting a functional relationship
between site II occupancy and the capacity for
transcription. Serum stimulation of quiescent pre-confluent
162
cells results in an up-regulation of HiNF-D binding activity
as the cells are resuming DNA synthesis and H4 histone gene
transcription. Density inhibited quiescent cells respond to
seru stimulation with only a minimal up-regulation of the
HiNF-D binding activity, 30% of maximal levels. However, H4
histone gene transcription is stimulated to a level equal to
that detected in extracts of the sparsely populated seru
stimulated cultures. These results suggest that there is a
threshold level of HiNF-D binding activity necessary for the
activation of H4 histone gene transcription. Additionally,
these findings suggest that there may be a mechanism
repressing HiNF-D binding activity in the density inhibited
cul tures which is not operative in the sparsely populated
seru deprived cultures. Density inhibited cultures may have
reached a state analogous to the initial steps of
differentiation and have invoked a series of mechanisms to
down-regulate expression of proliferation-specific factors.
Seru stimulation is able to overcome the one mechanism
down-regulating HiNF-D in both sparsely populated and
density inhibited quiescent cultures but is unable to
reverse the repression of proliferation-specific factors
which occurs in density inhibited cultures. These results
are consistent with the presence of at least two levels of
control over the HiNF-D/Site II interaction which are
responsive to and reflect the proliferative state of the
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cell and the extent to which the cell exhibits properties
associated with differentiation.
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Introduction
The control of growth related genes is central to
maintaining stringent cell cycle control, regulating the
transition between proliferation and a commitment to
differentiate, and maintaining the ordered sequence of
events leading to the development of a differentiated
phenotype. Understanding molecular mechanisms operative in
regulating expression of cell cycle and cell growth related
genes should provide insights into the loss of growth
control in transformed and tumor cells. The human H4 histone
gene F0108 (181) is a cell cycle dependent , growth related
gene for which expression is temporally and functionally
coupled to DNA synthesis (160). Regulation of this coupling
is mediated at both the transcriptional and post-
transcriptional levels (14). This H4 histone gene exhibits 
basal level of transcription throughout the cell cycle with
a two to three fold enhanced level of transcription during
the early stages of S phase (14 and A. Ramsey-Ewing,
personal communication). This is accompanied by an
accumulation of histone MRA which is rapidly and
selectively destabilized at the conclusion of DNA
replication (14 89).
Two in vivo protein-DNA interactions, site I and II,
have been delineated within the first 200 nucleotides
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upstream of the transcription initiation site (157, 158). At
least three independent protein factors have been detected
to bind to these domains in vitro (202) and Chapter 2 of this
thesis). HiNF-C, an Sp1-like protein, and HiNF-E, an ATF
related transcription factor, bind adj acent to each other in
the site I domain. The interactions at site I do not change
during the cell cycle nor during the complete shutdown of H4
histone gene transcription that occurs during
differentiation (152, 157, 193). However, deletion of site I
reduces transcription five to seven fold in actively
proliferating cells (112, 202 and Chapter 2 of this thesis).
This implies that site I is key in regulating the level of
H4 histone gene transcription but is not a rate limiting
step in the process of initiation.
Factor HiNF-D interacts specifically with site II
sequences at -20 to -70 nucleotides upstream from the
transcription initiation site. The region of interaction
includes the histone specific element (5' -GGTCC-3 ' ), a CAAT
box, and lies adjacent to the TATA box (202). Deletion of
this protein-DNA interaction site abolishes transcription 
vivo and indicates a critical role for site II in the
regulation of this gene (112). Furthermore, HiNF-D binding
activity is down-regulated outside of S phase in normal
diploid cells implying an involvement in the cell cycle
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control of histone gene expression. The level of HiNF-D
binding acti vi ty is un-coupled from the cell cycle in tumor
cells where constitutively high binding activity is detected
(95). In addition, in vivo site II interactions and HiNF-D
binding acti vi ty are specifically lost at the onset of
differentiation of HL60 cells into monocytes , concomitant
with the shutdown of H4 histone gene transcriptio (193). A
similar correlation between HiNF-D interaction with site II
and H4 gene transcription is seen at the onset of
differentiation in primary cultures of rat calvarial
osteoblasts (152). HiNF-D binding and H4 histone gene
transcription are lost simultaneously as the cells reach a
transition point where growth related genes are down-
regulated and tissue specific gene expression is initiated.
These observations prompted us to address further the
relationship between histone gene expression and cell growth
control. Human diploid fibroblasts provide a system in which
proliferation can be reversibly shut down without inducing
differentiation (12, 57, 154 162). Normal fibroblasts will
cease to proliferate and enter a quiescent state if placed
in medium containing very low serum (0 - 0. 5%) or if allowed
to become density inhibited. Sparsely populated cultures
maintained in serum free medium become arrested in the G
phase of the cell cycle due to a lack of nutrients. However,
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density inhibited fibroblasts become arrested in the G
phase and enter Go only after being maintained at reduced
seru concentrations (57). Seru deprived quiescent cultures
of either pre-confluent or confluent cells can be stimulated
to re-enter the proliferative phase upon replenishment of
the medium with 10% seru.
In these studies we have manipulated the proliferative
state of the cells and examined the extent to which the
level of HiNF-D binding at site II is coupled to H4 histone
gene transcription. A strict correlation between
proliferation, the presence of the HiNF-D binding activity,
and the ability of the H4 histone gene to be transcribed has
been established. However, stimulation of the density
inhibited cultures induced a significantly lower level of
HiNF-D binding activity than stimulation of the sparsely
populated cul tures despite approximately equivalent levels
of induction of H4 histone gene transcription. These results
suggest that the density inhibited cells are competent to
generate a threshold level of HiNF-D necessary to activate
H4 histone gene transcription upon serum stimulation but
have a mechanism restricting the accumulation of the
quantities of HiNF-D normally present in actively
proliferating cells. This mechanism may be related to the
limited proliferative activity displayed by serum stimulated
densi ty inhibited cells which in turn may be a reflection of
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the similarity between the density inhibited state and the
initial steps of differentiation.
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Materials and Methods
Human di loid fibroblast cell culture. The cells used
in these experiments were human diploid fibroblasts
originally derived from newborn foreskin and designated CF-3
(52). These cells have an in vitro life span of 65 +/- 10
population doublings and were used before 50% of this life
span had been completed. Cells were subcultured into 150 cm
plastic culture vessels (Costar) with McCoy' s Medium Sa
(Gibco) containing 10% fetal bovine serum (Hyclone) and
antibiotics as previously described (57). Cells were in
exponential growth phase three days after subculture and
formed confluent monolayers after seven days. stock cultures
were determined to be free of mycoplasma contamination by
the method of (11). In some experiments, cells were induced
to enter a quiescent state by replacing the medium
containing 10% serum with seru-free medium 24 hours
following subculture. These sparsely populated cultures were
maintained with serum-free medium for 72 hours at which time
the cells were stimulated to enter the division cycle by
refeeding with medium containing 10% serum. In other
experiments , a quiescent state was induced in confluent
populations by maintaining the cells for 16 days with medium
containing 0. 1% serum which was replaced twice weekly. These
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cells were also stimulated to enter the division cycle by
refeeding with medium containing 10% seru.
DNA S nthesis. DNA synthesis was estimated by the
incorporation of 3H-thymidine into acid precipitable
material as described previously (194). Cells were pulse
labeled for 30 minutes with o. 5 Ci/ml of 3H-thymidine (New
England Nuclear, 82. 7 Ci/mmol). Labeled cells were scraped
into phosphate buffered saline, pelleted by low speed
centrifugation , and resuspended in high salt buffer (0. 05 M
HP04' 2. 0 M NaCl, pH7. 4). Trichloro-acetic acid was added
to 10% (wt/vol) and TCA precipitable material was collected
on o. 45 m nitrocellulose filters. The filters were washed
3 times with 5 ml cold 10% TCA and dissolved in 1 ml
ethylene glycol monoethyl ether (cellusolve). Radioactivity
was determined by liquid scintillation spectrometry in 10 ml
of scintillation cocktail (72% toluene, 24% (vol/vol)
cellusolve and 4. 2% (vol/vol) Liquifluor (Research Products
International) ). An aliquot of the cell suspension was also
taken for the determination of DNA by the method of Labarca
and paigen (114).
Nuclear Extract Isolation. The isolation of nuclear
extracts from normal diploid cells was essentially as
described in Chapter 2 except the cells were lysed by
expelling the swollen cell suspension through a 22 gauge
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needle 10 times. All volumes were reduced to a minimum to
aid in the recovery of highly concentrated extracts.
Gel Mobilit Shift Assa Binding reactions were as
described in Chapter 2 except 2 g of poly (dI-dC)' (dI-dC)
was used as the non-specific competitor. The electrophoresis
buffer conditions for the gel mobility shift assay were
changed to a low ionic strength buffer (6. 6 ro Tris-HCl
(pH 7. 9), 3. 3 ro Na-acetate, and 1 ro EDTAJ as described
(67) .
mRA Isolation. Total cellular mRA was isolated
essentially as described previously (212). Cells from 2 - 4
T150 flasks were collected by centrifugation and stored at
-70 C. Nucleic acids were isolated by resuspending the
frozen pellet in 400 l of Lysis buffer (2 ro Tris-HCl
(pH 7. 4), 1 ro EDTA, 10 g/ml polyvinylsulfate (PVS , Kodak),
2% SDS and 500 g/ml Proteinase K (Bethesda Research
Laboratories) J and incubating for 30 minutes at 22 C. NaCl
was added to 0. 25 M and the reaction was repeatedly
extracted with phenol: CHCl : isoamyl alcohol followed by
ethanol precipitation. The nucleic acid pellet was
resuspended in 3 00 l of TCM buffer (10 ro Tris-HCl
(pH 7. 5), 2 ro caC12' 10 ro MgC1 2' and 10 g/ml polyvinyl
sulfate) and digested with 30 l of DNase I Solution for 
hours at 3 7 C. DNase I was prepared by resuspending 3. 4 mg
of crude DNase I (2000 units, Sigma) in 1 ml of 20 ro
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Tris-HCl (pH 7. 5), 10 ro cacl2 and incubating at 37 C for 20
minutes followed by the addition of Proteinase K to 1 mg/ml
and incubating the reaction an additional 2 hours at 37
The DNase I Solution was then stored on ice until used. RNA
was recovered by making the solution 1. 7% SDS and repeatedly
extracting and ethanol precipitating as before. The RNA was
resuspended in 150 l H 0 and stored at -70
Sl Nuclease Anal sis. The Sl nuclease analysis was as
described in Chapter 
In Vitro Transcri tion. In vitro transcription from
circularized templates was as described in Chapter 
Plasmids containing the first 536 base pairs of the
adenovirus maj or late promoter (pMLH1) have been described
previously (88).
173
Resul ts
Cessation of roliferation is associated with the down-
lation of HiNF-D indin acti vi t and H4 histone ene
transcri tion. Human diploid fibroblasts derived from
newborn foreskin (52) were examined during exponential
growth and two modes of induced quiescence: i) serum
deprivation and ii) density dependent quiescence. The
proliferative state of the cultures was monitored by the
level of DNA synthesis detected by 3H-thymidine
incorporation. Sparsely populated, proliferating cultures
were incubated for three days in serum free medium. DNA
synthesis in these serum deprived cultures was reduced to
5% of the proliferating rate , indicating that the cells
had entered a quiescent state (Table 4-1). Density
dependent , quiescent populations were also prepared by
maintaining cultures in normal growth medium without sub-
cultivation. Eight days after initial seeding the cultures
had reached confluence and were quiescent as reflected by a
94% reduction in the rate of DNA synthesis. Maintaining the
cultures at confluence for an additional one or two days
(Table 4-1, Day 9 and Day 10) did not further reduce the
rate of 3H-thymidine incorporation into the DNA.
HiNF-D binding activity was measured in the quiescent
fibroblasts as the loss of the HiNF-D/Site II interaction
has been shown to be correlated with the down-regulation of
Table 4-1. DNA s nthesis. Cells were pulse labeled with 3
thymidine for 30 minutes and incorporation into acid
precipitable material was used to estimate DNA synthesis as
described in the Experimental Procedures.
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TABLE 4-
: 1
" !
SAMP LE
H- TDR
DPMI J1G DNA
5 HRS
24 HRS
2262
2845
143
158
119
3039
EXPONENTIALLY GROWING
PRE-CONFLUENT - SERUM
PRE-CONFLUENT - SERUM
PRE-CONFLUENT - SERUM
CONFLUENT - 8 DAYS
CONFLUENT - 9 DAYS
CONFLUENT - 10 DAYS
CONFLUENT - SE UM DEPRIVED
CONFLUENT - SERUM STIMULATED,
CONFLUENT - SERUM STIMULATED,
DEPRIVED
STIMULATED, 5 HRS
STIMULATED, 24 HRS
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H4 histone gene transcription occurring at the onset of
differentiation (152, 193). High salt nuclear extracts were
prepared from proliferating cells and from quiescent cells
induced by serum deprivation or density dependent
inhibition. Gel mohility shift assays were utilized to
detect the level of HiNF-D binding to site II of the F0108
H4 promoter in each of the nuclear extracts. The rapidly
proliferating cells contained a high level of HiNF-D binding
activity (Figures 4-1 and 4-2). However, cells which had
ceased to proliferate due to three days of serum deprivation
lost 98% of the HiNF-D interaction with site II, to nearly
undetectable levels (Figure 4-1). Similarly, the density
dependent quiescent fibroblasts contained only 15% of the
HiNF-D binding activity as compared to the level in the
initial rapidly proliferating cultures (Figure 4-2).
The effect of the loss of interaction between HiNF-D
and site II on histone mRA levels and gene transcription
was determined in these cultures. H4 mRA levels were
detected by Sl analysis of total cellular RNA in order to
resolve the F0108 H4 gene from the other members of the H4
mul ti-gene family. The mRA levels paralleled HiNF-D binding
activity and DNA synthesis as would be expected of a cell
cycle regulated histone gene (Figures 4-3 and 4-4). The high
levels of H4 mRA present in the proliferating fibroblasts
were com letely down-regulated in quiescent cells. More
Fiqure 4-1. Anal sis of HiNF-D bindin activit in re-
confluent CF-3 normal di loid fibroblasts. A radiolabeled
DNA fragment (-155 to +18 bp) containing the site II domain
of the human H4 histone gene was used in a gel mobility
shift assay to probe for HiNF-D binding activity in nuclear
extracts. Nuclear extracts prepared from proliferating
normal diploid fibroblast cultures, cultures arrested for 72
hours in serum-free medium, and cultures 5 and 24 hours
after stimulation with medium containing 10% serum. Each
three lanes represent increasing concentrations of nuclear
extract added to the binding reactions. Arrow indicates
position of the HiNF-D/Site II complex.
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Figure 4-2. Anal sis of HiNF-D bindin activit in densit
inhibited CF-3 normal di loid fibroblasts. Gel mobility
shift analysis conditions are the same as in Figure 4-1.
Nuclear extracts were prepared from proliferating cultures
quiescent cultures 8, 9, and 10 days after initial plating,
cultures arrested in 0. 1% seru containing medium for 16
days after reaching confluence, and cultures 5 and 24 hours
after stimulation with 10% seru containing medium. Each
three lanes represent increasing concentrations of nuclear
extract added to the binding reactions. Arrow indicates
position of the HiNF-D/Site II complex.
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Figure 4-3. ression of human H4 histone mRA in re-
confluent normal di loid fibroblasts as a function 'of serum
arrest and stimulation. Cultures were maintained as
described in Figure 4-1 and total cellular RNA was isolated
from proliferating, seru arrested and seru stimulated
cuI tures as described in the Experimental Procedures. The
F0108 H4 histone mRA was specifically assayed by Sl
nuclease protection. Arrow head indicates accurately
initiated H4 histone mRA.
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Figure 4-4. ression of human H4 histone mRA durin
densi t inhibition serum arrest and serum stimulation of
normal di loid fibroblasts. cultures were maintained as in
Figure 4-2 and total cellular RNA was isolated from
proliferating, confluent cultures 8, 9, and 10 days afterplating, confluent cultures arrested in 0. 1% serum for 16
days and 5 and 24 hours after seru stimulation. The
arrowhead indicates the accurately initiated human H4 mRA
as detected by Sl nuclease protection.
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importantly, in vitro transcription of this gene by the same
nuclear extracts used to monitor HiNF-D binding revealed
transcription also paralleled the HiNF-D/Site II binding
activity and DNA synthesis (Figures 4-5 and 4-6). Nuclear
extracts from proliferating cells were able to initiate
transcription from the H4 histone gene promoter. However,
nuclear extracts from serum deprived and density dependent,
quiescent cells, which contained very low levels of HiNF-D
binding activity, were unable to support detectable levels
of in vitro transcription of the H4 histone gene.
Because quiescent cells may exhibit a reduced level of
general RNA polymerase II activity, each of the nuclear
extracts was assayed for in vitro 
transcription activity on
the adenovirus 2 maj or late promoter. While prolonged
quiescence resulted in a gradual decay of the general
polymerase activity, the quiescent cell extracts which were
devoid of H4 histone gene transcription activity still
exhibited a significant level of adenovirus transcription
(Figure 4-7). These results suggest that the quiescent cells
have selectively down-regulated transcription of the histone
gene. Furthermore, these findings support previous
observations demonstrating a requirement for the occupancy
of site II by HiNF-D in the initiation of H4 histone gene
transcription (193). They also indicate a common site of
Figure 4-5. Assessment of s ecific H4 histone ene
transcri tional acti vi t in re-confluent human di loid
fibroblasts. Cell free transcription analysis was performed
as described in the Experimental Procedures and resultant
RNA transcripts were assayed by Sl nuclease protection.
Nuclear extracts were the same as used in the determination
of HiNF-D binding activity as described in Figure 4-1. The
arrowhead indicates the accurately initiated human H4 mRA.
187
..,
Serum
Stimulation
5hr 24hr ::
"", . ....'
Cap Site 
Figure 4-6. Assessment of s ecific H4 histone ene
transcri tional activit durin densit inhibition serum
arrest and stimulation of confluent normal di loid
fibroblasts. Nuclear extracts were the same as used in the
determination of HiNF-D binding activity as described in
Figure 4-2. Cell free transcription was performed as
described in the Experimental Procedures. 'The arrowhead
indicates the accurately initiated human H4 mRA.
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Figure 4-7. Estimation of the eneral RNA ol erase II
acti vi tv Dresent in the nuclear extracts. The level of cell
free transcription from the adenovirus 2 maj or late promoter
(plasmid construct pMLH-1) (88) was used to demonstrate
general RNA polymerase II activity in the nuclear extracts
which have specifically down-regulated human H4 histone gene
transcription. A) Proliferating normal diploid fibroblasts(lane 1), pre-confluent seru arrested cultures (lane 2),
pre-confluent serum stimulated cultures 5 hours (lane 3) and
24 hours (lane 4) after stimulation, density inhibited
cultures 8 (lane 5), 9 (lane 6), and 10 days (lane 7) after
initial plating, density inhibited, seru arrested cultures
(lane 8), and density inhibited, serum stimulated cultures 5hours (lane 9) and 24 hours (lane 10) after stimulation. RNA
transcripts were assayed by Sl nuclease protection as
described in the Experimental Procedures. Broad arrowhead
indicates the accurately initiated transcripts. 
Graphical comparison of the general RNA polymerase II
activity (Adenovirus) with the specific histone H4
transcriptional activity. The samples are presented in the
same order is described in part 
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action (HiNF-D/Site II) for the down-regulation of
transcription occurring at the onset of differentiation,
seru deprived quiescE nce, or density dependent quiescence.
Serum stimulation of s arselv o ulated fibroblast
cul tures -re ulates HiNF-D bindin acti vi t and H4 histone
ene transcri tion. Quiescent fibroblasts, in contrast to
terminally differentiated cells, can be stimulated to
re-enter the proliferative cycle (214). This system provides
the opportunity to address the molecular mechanisms
operative during the re-activation of histone gene
expression and the role of the HiNF-D/Site II interaction in
this process. sparsely populated cultures were maintained in
serum free medium for three days to induce the cells to
enter a quiescent state and to down-regulate histone gene
transcription and HiNF-D binding activity. The cultures were
then stimulated by replacing the depleted medium with fresh
medium containing 10% serum. The cells required
approximately fourteen hours to exit the G, phase and enter
the DNA replication period. The maximal rate of DNA
synthesis occurred twenty four hours post-stimulation as
reflected by the rate of 3H-thymidine incorporation into DNA
(Table 4-1).
The onset of DNA synthesis requires histone protein
synthesis to package the newly replicated DNA and the
194
ini tiation of S phase is marked by a large increase in
histone mRA levels and elevated transcription in cycling
cells (160). The same temporal and functional coupling of
histone mRA levels and DNA replication was demonstrated
following serum stimulation of quiescent, serum deprived
cells. Total cellular mRA was isolated at five and twenty
four hours after stimulation and assayed for F0108 H4
histone mRA. H4 histone mRA was not detectable in the
quiescent cells or cells five hours after stimulation
(Figure 4-3) but then accumulated dramatically in
conjunction with maximal DNA synthesis at twenty four hours
post-stimulation to levels found in rapidly proliferating
populations.
Transcription of this H4 histone gene was monitored
during serum stimulation and correlated with the presence of
HiNF-D binding activity. High salt nuclear extracts were
prepared from serum deprived cells and cells five and twenty
four hours after serum stimulation. Nuclear extracts from
the quiescent cultures and cultures five hours post-
stimulation were unable to support detectable levels of
in vitro transcription from the F010S H4 histone gene
(Figure 4-5). At twenty four hours after stimulation, when
the fibroblasts had initiated DNA replication and histone
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mRA levels were elevated , the capacity for in vitro
transcription of the H4 gene was recovered.
Each of the high salt nuclear extracts used for in vitro
transcription was assayed for the presence of HiNF-D/site II
binding activity. The quiescent and five hour post-
stimulation fibroblasts had down-regulated HiNF-D binding
activity to less than 2% of levels found in proliferating
cells, paralleling the down-regulation of proliferation and
loss of H4 histone gene transcription. When the fibroblasts
re-entered S phase and up-regulated H4 gene transcription,
there was a concomitant up-regulation of the HINF-D binding
activity (Figure 4-1). These results suggest that not only
is HiNF-D involved in the down-regulation of H4 histone gene
transcription occurring at quiescence, but it is also a
critical element in the re-activation of transcription
during serum stimulation.
Serum stimulation of densi inhibited fibroblasts u
lates H4 histone ene transcri tion but induces onl 
threshold levels of HiNF-D bindin activit Human diploid
fibroblasts will naturally cease to proliferate and enter an
extended quiescent state when the cultures are allowed to
become confluent. The density inhibited cultures can then be
induced to undergo limited proliferation by serum
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stimulation before returning to the quiescent state (12).
Densi ty dependent quiescence may be more analogous to
condi tions present in normal tissues. Thus, it is important
to determine whether the same mechanisms regulating histone
gene transcription are operational under these conditions.
Density inhibited, quiescent CF-3 fibroblasts were
maintained in medium containing 0. 1% serum for sixteen days.
The fibroblasts were then stimulated by replacing the medium
with fresh medium containing 10% serum. The time after
stimulation at which the fibroblasts entered S phase was
detected by 3H-thymidine incorporation into DNA. The density
inhibi ted cul tures exhibited the same time course of
stimulation as the sparsely populated , serum deprived
cultures, with maximum DNA synthesis occurring twenty four
hours post-stimulation (Table 4-1). H4 histone mRA levels
paralleled DNA synthesis during stimulation and were
indistinguishable from the time course observed when
sparsely populated fibroblast cultures were stimulated
(Figure 4-4).
The relationship between HiNF-D binding activity and H4
histone gene transcription was examined during the
stimulation of the density inhibited fibroblasts. High salt
nuclear extracts were prepared from the quiescent cultures
and cultures five and twenty four hours after serum
stimulation. Only nuclear extracts prepared from fibroblasts
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twenty four hours after stimulation were able to support
detectable levels of in vitro transcription (Figure 4-6). H4
histone gene transcription was up-regulated at twenty four
hours to 70% of the maximal level detected in rapidly
proliferating cells. Both density inhibited and sparsely
populated quiescent cells exhibited approximately the same
rate of H4 histone gene transcription during the peak in DNA
synthesis after serum stimulation.
Interestingly, ' the stimulation of HiNF-D' binding
activity in the density inhibited fibroblasts is not the
same as in the sparsely populated cultures. HiNF-D binding
activity is reduced to undetectable levels in the density
inhibited , serum deprived cultures. However, at twenty four
hours after stimulation, when H4 histone gene transcription
has returned to near maximal levels, HiNF-D binding activity
is up-regulated to only 30% of the level present in rapidly
proliferating cells (Figure 4-2). The small stimulation of
HiNF-D binding activity is in contrast to the near 100%
stimulation induced in the sparsely populated fibroblast
cul tures twenty four hours after stimulation.
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Discussion
The interaction between the proliferation specific
transcription factor, HiNF-D, and the H4 histone gene cis-
acting DNA element, site II, is required for initiation of
H4 histone gene transcription and has been demonstrated to
play a critical role in the down-regulation of transcription
occurring at the onset of differentiation. In the present
study we have investigated the role of this interaction in
regulating H4 histone gene transcription wi thin the context
of fibroblast quiescence and serum stimulation of
proliferation.
Rapidly proliferating normal diploid CF-3 fibroblasts,
derived from newborn human foreskin, have high levels of
HiNF-D binding activity and H4 histone gene transcription.
When sparsely populated cultures become quiescent due to
serum deprivation or density inhibition, H4 histone gene
transcription is down-regulated simultaneously with a loss
of HiNF-D binding activity. The parallel between the
specific down-regulation of HiNF-D binding activity and H4
histone gene transcription during quiescence is the same as
demonstrated for the cessation of proliferation occurring at
the onset of differentiation of HL60 cells and osteoblast
cells (152 193). These results suggest that regulation of
the HiNF-D/Site II interaction is an important event in the
down-regulation of H4 histone gene transcription. Moreover,
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regulation of this interaction may impinge on a common
mechanism associated with the down-regulation of cell growth
that accompanies differentiation, serum deprived quiescence
and density dependent quiescence.
sparsely populated cultures of quiescent fibroblasts
can be serum stimulated to re-enter the proliferative cycle.
This provides the opportunity to observe the re-activation
of H4 histone gene transcription and the role of the
HiNF-D/Site II interaction in this process. HiNF-D binding
activity is undetectable in the quiescent populations but is
up-regulated in parallel with the activation of H4 histone
gene transcription as the cultures resume proliferation.
This suggests that HiNF-D may not only be functionally
related to the down-regulation of H4 histone gene
transcription during the onset of quiescence or
differentiation but , additionally, may be a key element 
the up-regulation of transcription occurring during serum
stimulation of normal quiescent cells.
Normal human fibroblasts , when allowed to become
density inhibited, down-regulate proliferation and enter a
o resting state. This may be more analogous to the
conditions present in tissues. Serum stimulation of density
dependent, quiescent fibroblasts initiates proliferative
acti vi ty and the required H4 histone gene transcription.
However, HiNF-D binding activity is up-regulated to only 30%
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of maximal levels. Because H4 histone gene transcription is
activated to near normal levels, the 30% of HiNF-D binding
activity present may represent a threshold level of HiNF-D
required by the fibroblast. Furthermore, the difference in
activation of HiNF-D binding activity between serum
stimulation of sparsely populated quiescent fibroblasts and
density dependent quiescent fibroblasts indicates two
different mechanisms may be operational in the down-
regulation of HiNF-D binding activity.
One possible model for the regulation of the HiNF-D
binding activity observed incorporates a primary mechanism
controlling HiNF-D binding activity in actively
proliferating fibroblasts and fibroblasts which are serum
arrested but capable of proliferation. This may be the same
mechanism controlling the cell cycle regulation of HiNF-D
observed by Holthuis et al (1990) in normal diploid cells.
Upon density dependent quiescence and entry into the G
state, a second mechanism is activated to repress HiNF-D
binding activity. Serum stimulation is not able to
completely overcome this second level of repression. One can
speculate that the function of a second mechanism down-
regulating HiNF-D binding activity would be to control the
replication dependent H4 histone gene transcription in cells
which are programmed to remain quiescent or to undergo only
a limited amount of proliferation before re-entering a
'",
201
quiescent state. The appearance of an extracellular matrix
and cell to cell communication analogous to that found in an
intact tissue may be the means by which the cell is signaled
to enter a deeper quiescent state and activate a second
mechanism to down-regulate proliferation specific factors
such as HiNF-D. A process akin to the seru stimulation of
density inhibited cultures may be the limited proliferative
activity observed in dermal fibroblasts during wound healing
(201) .
In conclusion, the HiNF-D/Site II interaction plays a
cri tical role in the regulation of H4 histone gene
transcription. It is important during both the down-
regulation of proliferation at the onset of differentiation
and quiescence and the up-regulation of proliferation due to
serum stimulation of quiescent fibroblasts. HiNF-D binding
activity is regulated minimally at two levels dependent on
the proliferative state of the cell and the programmed
future requirements for H4 histone ' gene transcription.
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CHAPTER 5
DISCUSSION
Expression of the growth related F0108 human H4 histone
gene is regulated in response to both cell cycle progression
and the proliferative state of the cell. The control of
expression is mediated at both the transcriptional and post-
transcriptional levels. The investigation presented in this
dissertation has focused on the transcriptional aspects of
histone gene regulation.
We developed a cell free transcription system capable
of accurately initiating transcription fr m the H4 histone
gene promoter and utilized it to assess the functional
contribution of upstream sequence elements. Our results (for
a schematic reveiw of all of the results see Appendix 
identified the in vivo protein-DNA interaction domain site I
as a bipartite transcriptional activator element.
Furthermore, two distal activator elements and two potential
repressor elements were defined between -1000 and -200 base
pairs upstream of the initiation site. Employing a myriad of
in vitro techniques designed to detect protein-DNA
interactions we characterized the trans-acting factors
mediating the transcriptional stimulation from the activator
elements. The functionally bipartite site I element (-124 to
-90 base pairs) formed protein-DNA complexes with two
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distinct transcription factors, HiNF-E and HiNF-C. HiNF-E
bound to the distal side of site I and interacted with a
consensus recognition sequence for the ATF transcription
factor family. Binding site competition and mutagenesis
confirmed HiNF-E is a member of the family of ATF
transcription factors. The originally characterized ATF
transcription factors were 43 to 47 kDa, however, molecular
weight analysis of the HiNF-E binding site interaction
detected an 84 kDa protein. This is a novel molecular weight
for the ATF transcription factor family and thus we termed
it ATF-84. Additionally, purification by DNA affinity
chromatography and preliminary immunochemical analysis
suggested ATF-84 is structurally related to ATF-43/47.
HiNF-C binds adjacent to HiNF-E in site I and requires an
Sp1 like recognition sequence for binding. The binding
characteristics of HiNF-C, including a dependence on zn
are indistinguishable from the transcription factor Sp1.
Because extensive studies of Sp1 have not shown it to be
part of a family of related factors, these observations
strongly suggest HiNF-C and Sp1 are identical. In addition
to the stimulation of transcription exerted by HiNF-CjSp1,
binding of this factor to site I dramatically stabilized the
adjacent interaction of the HiNF-E/ATF-84 factor. This
interaction may be a key to the preferential binding of the
84 kDa ATF factor to the H4 histone promoter and may be an
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important aspect in the regulation of this gene. Recently,
Tj ian and co-workers have described an Spl-Spl interaction
which can synergistically activate transcription and Janson
& pettersson (101) have characterized a cooperative binding
interaction between Sp1 and OTF-1. These results together
suggest that protein-protein interactions involving Sp1 may
be a common mechanism for the regulation of transcription
(44) .
The near-distal activator region (-418 to -213 base
pairs) stimulated transcription 2 - 4 fold and formed a
single protein-DNA complex, H4UA-1. The binding site for
H4UA-1 contained recognition sequences for both the CTF/NF-1
transcription factor and the thyroid hormone receptor (TRE).
Interestingly, hormone response elements are commonly
clustered with recognition sites for other transcription
factors and both simultaneous and competitive binding of the
factors has been observed ( 15 , 26, 177 , 196). However, as yet
little is known about the role of dual binding affinities at
hormone response elements. The presence of a hormone
response element in the human H4 histone gene suggests a
direct mechanism by which histone gene transcription can
rapidly respond to changes in growth due to hormone
induction.
The far-distal activator region (-730 to -589 base
pairs) was the strongest activator detected, stimulating
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transcription 10 fold. A complex pattern of protein-DNA
interactions consisting of at least three factors was
detected in this region. Two of the factors, H4UA-3 and
H4UA-4, bound to previously undescribed recognition
sequences, however, H4UA-2 interacted at a second ATF
recognition sequence. Binding site competition studies
between HiNF-E and H4UA-2 demonstrated that they interacted
wi th similar factors and a molecular weight determination of
the factors binding at H4UA-2 detected an 84 kDa protein.
Because ATF-84 has not been detected by laboratories
investigating ATF binding activities in other promoters,
these results suggest that ATF-84 may be directed
specifically to histone promoters. An ATF binding site has
been localized in the first 200 base pairs of the ST519
human H3 histone gene promoter (A. van Wijnen, personal
communication) and in a wheat H3 histone gene promoter
(198). Furthermore, a search of published histone promoter
sequences detects several potential binding sites for ATF.
It will be important to determine if ATF-84 is selectively
used in these histone promoters as well, which would provide
the first evidence of a mechanism to coordinately regulate
different types of histone genes.
The F0108 H4 human histone gene promoter contains a
second jn vjvo protein-DNA interaction domain, site II.
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Characterization of this domain by van Wijnen et al. (202)
has identified the nuclear factor HiNF-D and initial 
in vivo
and in vitro studies revealed the site II/HiNF-D interaction
to be preferentially lost during differentiation (193). Our
findings extended these results to normal diploid cells and
demonstrated that HiNF-D is a proliferation-specifi
transcription factor required to switch on H4 histone gene
transcription. HiNF-D binding activity paralleled the loss
of histone gene transcription as normal diploid fibroblasts
entered a quiescent state. Furthermore, the binding activity
was activated in concert with the return of histone gene
transcription when the cells were stimulated to re-enter the
proliferative cycle. Recently, Holthuis et al. (95) has
shown HiNF-D binding activity to be regulated during the
cell cycle of normal diploid cells, suggesting this factor
is important for cell cycle control of transcription.
Additionally, promoter fusion constructs containing only the
site II domain are transcribed in a cell cycle manner
(A. Ramsey-Ewing, personal communication). However, the
HiNF-D/Site II interaction does not change during the cell
cycle of transformed cells despite the well documented cell
cycle regulated transcription of histone genes in these
cells. These results could be explained by a cell cycle
regulated modification in the activation domain of HiNF-D
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which in normal diploid cells would cause a loss of the
binding activity but in transformed cells would not effect
the binding activity. A second, more intriguing possibility
is that the H4 histone gene contains multiple cell cycle
elements which can compensate for the loss of any single
element. Due to the procedures (5' deletion analysis) by
which cell cycle elements have been investigated, only the
last most proximal element would be detected, in this case
HiNF-D/site II. A possible candidate for the second cell
cycle element is the HiNF-E/ATF-84 interaction at site 
The stimulatory activities of several of the ATF
transcription factor family members are responsive to
phosphorylati by the cAMP dependent protein kinase and one
has been described to respond to fluctuations of ca
inducible phosphorylation. It will be interesting to
determine if the activity of ATF-84 is also regulated by
phosphorylati and whether the changes in phosphorylati
occur in a cell cycle regulated manner.
The effects of the distal half of site II (the HiNF-D
binding site) on transcription 
in vivo and in vitro 
are
slightly different. 
In vivo, as assayed in stable cell lines,
the H4 histone promoter containing sequences only up through
the TATA box (proximal half of site II) is incapable of site
specific initiation of transcription, however, the addition
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of the remainder of Site II allows a low level of correctly
ini tiated transcription to occur. In contrast, the level and
specificity of in vitro transcription is indistinguishable
between the 5' deletion constructs either with or with out
the distal site II region. This result suggests that the 
vitro system has overcome the requirement for the
HiNF-D/Site II interaction and perhaps indicats HiNF-D plays
a role in opening up the initiation site for polymerase
entry but due to the relaxed torsional stress present 
vitro as compared to in vivo this activity is not required.
However , if a promoter containing site II and additional
upstream elements is assayed for transcription using a
nuclear extract deficient in HiNF-D/Site II binding activity
(seru arrested nuclear extracts) in vitro transcription
acti vi ty is not observed. One explanation for the
requirement HiNF-D in a promoter containing upstream
elements but not in a promoter without upstream elements
suggests HiNF-D may also be serving as a target for the
action of the distally located transcription factors present
only in the larger promoter.
A comparison of our results to those with other
vertebrate histone genes reflects limited similarities. The
primary focus of most research has been the identification
of cell cycle elements. Several groups have clearly
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demonstrated that the 5 I promoter region is sufficient to
direct cell cycle regulation of initiation (7, 28, 74, 151).
The highly conserved s,ub-type specific elements of the H1
and H2B histone genes are required for maintaining the
S phase specific stimulation of transcription (49, 64, 115).
Interestingly, the H2B element is a member of the ubiquitous
octamer binding transcription factor family, while the HI
histone element appears to be found only in Hl histone
genes. Partial characterization of a 32 base pair region in
the hamster H3 histone gene has identified a third cell
cycle element (8). These results combined with our data on
the H4 histone gene suggest that each of the histone gene
sub-types may have distinct cell cycle elements.
A second human H4 histone gene (Hu4a) has been studied
by Dailey et a 7. and two transcription factors which bind
within the first 120 base pairs have been partially purified
(47). H4TF-2 binds at the upstream side of the TATA box in a
region which is highly similar to the site II domain of the
F0108 H4 histone gene. Similar patterns of DNA contact
points have been described for H4TF-2 and HiNF-D, yet the
factors behave differently during purification. Although
these factors are undoubtablly related, the exact
relationship has yet to be determined. One intriguing
possibility is that H4TF-2 is a sUb-component of a much
" .;;.) "\ :
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larger HiNF-D complex which is not formed with the Hu4a
promoter. H4TF-1 is the second factor characterized as
binding to the Hu4a histone gene promoter and is positioned
at -113 to -90 base pairs. This factor binds to a G-C rich
element 5' -GGGGGAGGG-3' similar to the HiNF-C binding site.
However, the H4TF-1 binding site does not interact with 
Spl,
in contrast to the HiNF-CjSp1 interaction we described in
the F0108 H4 histone gene promoter. Interestingly, there is
an Spl binding site between the H4TF-1 and H4TF-2 
elements,
though interactions at this site have not been 
identified.
Thus it appears that the promoters of human H4 histone genes
have diverged substantially with the exception of the region
around the TATA box defined by site II. Additional studies
of the proximal and distal promoters of other human H4
histone genes will be required to understand fully the
mechanisms regulating coordinated and cell cycle controlled
transcription of H4 histone genes.
In summary, we have characterized several of the
cis-acting sequence elements and trans-acting transcription
factors mediating regulated transcription of a cell cycle
regulated human H4 histone gene. Our results have described
a promoter with a complex modular architecture extending at
least 1000 base pairs upstream of the transcription
initiation site and have defined both common and potentially
,"I
1" ;,
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histone specific transcription factors mediating the
regulation of transcription.
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APPENDIX A
COMPLETE SEQUENCE OF THE F0108 HUM H4 HISTONE GENE
002
GGATCCGTAGAACGGATGCACAGAATATCCCTCAGTCTTCTCTATGTAGCAGGCCCTCCA
-1000
CCTAGGCATCTTTGCCTACGTGTCTTATAGGGAGTCAGAAGAGATACATCGTCCGGGAGGT
TATACGCGGGTTCCCCAAGACCGAATATTAACAATGAATTTCTTTTTTAA
-950
ATATGCGCCCAAGGGGTTCTGGCTTTTATAATTTGTTTACTTAAGAATTTTTTTT
GTACAACAAGATAGTAATAACAGTTAACAATTACTTACATAGCTTTACACA
-900
CATGTTGTTTTCTATCATTTTTATTTTTGTCAATTTGTTAATGAATGTATCGAATGTGT
CTGGATTGGTGTTCGAAGTAATTTGAGCTTATTTAAGTACACGGGAGGATGTGCATAGT
-850
GACCTAACCACAAGCTTCATTAACTCGAATAATTTCATGTGCCCTCCTACACGTATCA
TATGTGCAATACTACCCCACTTTCTATGAGAGACTTGAGCAACCTGGATTTTGGTATCG
-750
ATACACGTTTATGATGGGGTGAAGATACTCTCTGAACTCGTTGGACCTAACCATAGC
IE9
GCGGGGGCCCTGGACCAATCCCCTCTCAGTTCTACCGAGGGAGAACTGTTTTGTTTCTTC
-700
CGCCCCCGGGACCTGGTTAGGGGAGAGTCAAGATGGCTCCCTCTTGACAACAAGAAG
CAGCACGGCTTTGACCGACAGTGTGTTGGGATTCGCTGACGTCCATGAGAAGCTTGGCA
-650
GTCGTGCCGAACTGGCTGTCACACAACCCTAAGCGACTGC GGTACTCTTTCGAACCGT
213
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GCATGCTGAGACCAATTTTCCCAGGGCCAGAATTCTCCTGTGTGAGCTAATACAGTGC
-600
CGTACGACTCTGGTTAAGGGTCCCGGTCTTAAGAGGACACACTCGATTTTATGTCACG
GTCGGTCCAACAAACAGAGCCTGGAGCCAGGAATTATGGCGAACCTGCTCCCTCCCGTC
-550
CAGCCAGGTTGTTTTGTCTCGGACCTCGGTCCTTAATACCGCTTGGACGAGGGAGGGCAG
CTCCCTTGGCGCACAGATCCCTGGCGCCGTCCTTGAGGTCGCCTTCGGTGTTGACCTCAT
-450
GAGGGAACCGCGTGTCTAGGGACCGCGGCAGGAACTCCAGCGGAAGCCACAACTGGAGTA
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CGTCGGAACGGCGCTTCCTGAAGCTTTATATAAGCACGGCTCTGAATCCGCTCGTCGGGA
-400
GCAGCCTTGCCGCGAAGGACTTCGAATATATTCGTGCCGAGACTTAGGCGAGCAGCCCT
TTAATCCTGCGC' l'GGCGGCCTCCTGCCAGTCTCTGGCCTCCATTTGCTCTTCCTGAGGC
-350
AATTTAGGACGCGACCGCCGGAGGACGGTCAGAGACCGGAGGTAACGAGAAGGACTCCG
TCCCTCCAGAGACCTTTCCCTTAGCCTCAGTGCAATGCTTCCGGGCGTCCTCAGACCAGA
-300
AGGGAGGTCTCTGGAAGGGAATCGGAGTCACGTTACGAAGGCCCGCAGGAGTCTGGTCT
108
CACAGCCAAGCCACTACAGAATCCGGAAGCCCCGGTTGGGATCTGAATTCTCCCGGGGA
-250
GTGTCGGTTTCGGTGATGTCTTAGGCCTTCGGGGCCAACCCTAGACTTAAGAGGGCCCCTI L14 I K8
CTGTGGCGTCAGGTTAAGAGTGAGAGGGACCTGAGCAGAGTGGAGGAGGA
-150
GACACCGCAGTCCAATTTTTTTTTTTTCTCACTCTCCCTGGACTCGTCTCACCTCCTCCT
214
IJ50
GGGAGAGGAACAGAAGAATGACGAATGTCGAGAGGGCGGGGACAATTGAGAACG
-100
CCCTCTCCTTTTGTCTTTTCTTTACTGCTTTACAGCTCTCCCGCCCCTGTTAACTCTTGC
IJ56 I J67
CTTCCCGCCGGCGCGCTTTCGGTTTTCAATCTGGTCCGATACTCTTGTATATCAGGGGAA
-50
GAAGGGCGGCCGCGCGAAGCCAAGTTAGACCAGGCTATGAGAACATATAGTCCCCTT
GACGGTGCTCGCCTTGACAGAAGCTGTCTATCGGGCTCCAGCGGTCATGTCCGGCAGAGG
CTGCCACGAGCGGAACTGTCTTCGACAGATAGCCCGAGGTCGCCAGTACAGGCCGTCTCC
AAGGGCGGAAGGCTTAGGCAAGGGGGCGCTAAGCGCCACCGCAAGGTCTTGAGAGA
TTTCCCGCCTTTTCCGAATCCGTTTCCCCCGCGATTCGCGGTGGCGTTCCAGAACTCTCT
CAACATTCAGGGCATCACCAAGCCTGCCATTCGGCGTCTAGCTCGGCGTGGCGGCGTTAA150
GTTGTAAGTCCCGTAGTGGTTCGGACGGTAAGCCGCAGATCGAGCCGCACCGCCGCAATT
GCGGATCTCTGGCCTCATTTACGAGGAGACCCGCGGTGTGCTGAAGTGTTCTTGGAGAA200
CGCCTAGAGACCGGAGTAATGCTCCTCTGGGCGCCACACGACTTTCACAAGAACCTCTT
TGTGATTCGGGACGCAGTCACCTACACCGAGCACGCCAAGCGCAAGACCGTCACAGCCAT250
ACACTAAGCCCTGCGTCAGTGGATGTGGCTCGTGCGGTTCGCGTTCTGGCAGTGTCGGTA
GGATGTGGTGTACGCGCTCAAGCGCCAGGGGAGAACCCTCTACGGCTTCGGAGGCTAGGC
300
CCTACACCACATGCGCGAGTTCGCGGTCCCCTCTTGGGAGATGCCGAAGCCTCCGATCCG
215
GCCGCTCCAGCTTTGCACGTTTCGATCCCAAGGCCCTTTTTGGGCCGACCACTTGCTCA
350
CGGCGAGGTCGAACGTGCAAGCTAGGGTTTCCGGGAACCCGGCTGGTGAACGAGT
TCCTGAGGAGTTGGACACTTGACTGCGTAAGTGCAACAGTAACGATGTTGGAAGGTAAC450
AGGACTCCTCAACCTGTGAACTGACGCATTTCACGTTGTCATTGCTACAACCTTCCATTG
TTTGGCAGTGGGGCGACATTCGGATCTGAAGTTAACGGAAGACATAACCGC500 
AACCGTCACCCCGCTGTAAGCCTAGACTTCAATTGCCTTTCTGTATTGGCG
A
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